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ABSTRACT 
 
Our lab has identified the functional metabolites of Diamond V Original XPC
TM 
(XPC) as a potential strategy to be used by the poultry industry to enhance immune 
function and poultry health. Three experiments were conducted using Ross 308 birds to 
determine the immunomodulatory capacity of XPC in the adaptive immune system of 
broilers. In the first experiment (n=240), birds were randomly assigned to either a 
control or XPC diet. Newcastle Disease Virus (NDV)-specific humoral immune 
response to a live attenuated vaccine was significantly (P<0.05) higher in XPC at d42. 
Flow cytometry showed no significant differences in cell populations (P>0.05) between 
treatments on the same sampling days. In Experiment Two (n=640), birds were 
randomly assigned to an unvaccinated or vaccinated group and further assigned to XPC 
or control diets. At d1, live NDV LaSota strain vaccine was used as a primary 
immunization to evaluate its impact on adaptive immunity. Remarkably, no substantial 
NDV-specific humoral immune response was established. Body weights were 
significantly higher (P<0.05) in the vaccinated birds on days 4 and 7. Spleen index of the 
vaccinated birds was significantly (P<0.05) lower at day 28 and 35. In Experiment Three 
(n=180), the role of maternal antibodies on XPC’s immunomodulatory capacity was 
evaluated. A factorial arrangement of three vaccination protocols and two diets (XPC or 
Control) was used. Protocol 1 used live B1 strain as primary immunization whereas 
Protocol 2 used live LaSota strain. Protocol 3 used live LaSota strain after maternal 
antibodies had decayed. In Protocol 1, XPC birds’ NDV titers were significantly higher 
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(P<0.001) at day 28. Protocol 3 resulted in the highest NDV-titer level during the trial; 
XPC birds reached a significantly (P<0.001) higher level than control birds on d35. 
Protocol 2 had the lowest NDV-titer. Feed conversion was significantly higher (P<0.05) 
in Protocol 3 compared to 1 and 2. Overall, the results indicate that XPC 
supplementation positively modulates the broiler immune system, allowing it to have a 
robust and significantly higher NDV-specific humoral immune response compared to a 
control diet; its immunomodulatory capacity appears to be potentiated by the level of 
maternal antibodies and the vaccination schedule.  
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1. INTRODUCTION
The poultry industry has evolved to become an effective, high yield, and 
economically feasible industry through the development of better ventilation, housing, 
animal care, and intense research. However, due to high levels of production and use of 
antibiotics in combination with consumer demand and media pressure the poultry 
industry has been forced to develop new strategies for pathogen control, animal health, 
and food safety without the use of antibiotics. Dietary supplementation with the 
functional metabolites from a Saccharomyces cerevisiae fermentation product, Diamond 
V (Cedar Rapids, Iowa) Original XPC
TM
 (XPC), have been identified by our lab as a
potential strategy to be used by the poultry industry, particularly in antibiotic free 
programs (ABF). The need to find effective, economically feasible and practical 
strategies in order to maintain high levels of production in the poultry industry while 
continuing appropriate animal care has become a top priority in the industry around the 
world and therefore it is imperative to continue thorough research in that field. 
Yeast products have been studied for a long time for their properties as natural 
growth promoters and potential immune modulators. Initially, the use of Saccharomyces 
cerevisiae as a growth promoter in ruminants was reported by Eckles and Williams, 
1925. Gao et al., 2008 described a linear increase in antibody titers to Newcastle Disease 
Virus (NDV) when the level of yeast extract fed to birds increased and suggested its 
potential modulation of systemic immunity.  Efficient poultry production cannot be 
accomplished without birds achieving their full genetic potential and one crucial piece in 
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order to accomplish a high level of success is good animal health. The immune system in 
broilers plays a major role in every aspect of a broiler’s life. However, much more 
research is necessary in order to achieve a better understanding of the processes and 
effector mechanisms of the avian immune system. This important system allows a 
modern broiler to successfully defend itself from pathogens and maintain a high level of 
growth and excellent feed conversion which allows for economic gains and sustainable 
practices. The strategies that aim to achieve a strong immune system and as a result 
provide strong animal health allow for the preservation of high production levels without 
the use of antibiotics. These strategies rely on their ability to modulate the immune 
system or enhance immune response to a particular antigen. 
The objectives of this study are: 1) to further study the immunomodulatory 
capacity of the functional metabolites of Saccharomyces cerevisiae fermentation product 
XPC on the adaptive immune system of broilers. 2) Analyze the overall Newcastle 
Disease Virus-specific antibody serum IgY titers of broilers in response to vaccination 
throughout the duration of a typical production cycle. 3) Measure immune-associated 
parameters in early stages of immune system development (day 4 and 7 post-hatch) as 
well as early post-boost (day 24 instead of day 28). 4) Evaluate the impact of a 1x dose 
of live LaSota strain NDV vaccine administered oculo-nasally on days 0 and 21 on early 
development of humoral and cell-mediated immune response in broilers. 5) Assess the 
influence of maternal derived antibodies on the efficacy of XPC in birds vaccinated with 
live NDV vaccine. 
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The information obtained at the end of this study will help provide a deeper 
understanding of the immunomodulatory capacity of XPC in broilers. The results will 
help determine the extent of the immunomodulatory capacity of XPC. This study will 
help improve the understanding of the multiple factors that could influence its function 
and interaction with the broiler’s adaptive immune system. In addition, the results will 
aid the research and agricultural community to evaluate the potential use of XPC as an 
effective strategy to help maintain animal health and enhance immune function.  
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2. LITERATURE REVIEW 
 
2.1 Newcastle Disease  
The development of the different effector mechanisms of the chicken adaptive 
immune system have been further studied in recent decades. In order to maintain a high 
level of production while upholding animal health at all levels of the production cycle 
one has to understand the way the early development of the chicken adaptive immune 
system will be able to effectively combat pathogens in a commercial production setting. 
Modern poultry production results in birds being exposed to multiple immunological 
challenges starting at the hatchery.  
A disease of poultry that was first described in 1926 is Newcastle Disease (ND) 
and ever since it has been a major problem in the poultry industry primarily because of 
its worldwide distribution and economic impact. As a result, multiple strategies exist to 
combat this disease which can be effectively managed with good biosecurity programs 
and effective vaccination programs. The causative agent of ND is Newcastle Disease 
Virus (NDV) and all strains of NDV belong to the family Paramyxoviridae, genus 
Avulavirus, and they are part of one serotype avian paramyxovirus serotype-1 (APMV-
1); this virus is an enveloped negative single-stranded RNA virus (Alexander and Senne, 
2008).  
NDV was isolated for the very first time in 1926 from chickens in Newcastle, 
England and it was through the use of serological and structural tests, and genetic 
properties that nine distinct groups of avian paramyxoviruses were identified (Poultry 
Diseases, 2008). In modern poultry, producers develop vaccination programs that aim, 
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among many other objectives, to protect against NDV and reduce potential economic 
losses as result of loss of live birds, loss of performance or loss due to condemnations at 
the processing plant.  Antibodies will prevent NDV growth in the visceral organs but the 
virus will still be able to replicate at the mucosal surfaces and thus resulting in the virus 
still being excreted by infected birds (McFerran and McCracken, 1988). Currently, three 
main types of commercially available vaccines for Newcastle disease: live lentogenic, 
live mesogenic and inactivated are available to the poultry industry.  
The lentogenic strains are of low pathogenicity but are capable of inducing a 
successful immune response. In contrast, mesogenic strains are derived from fully 
virulent strains and inactivated vaccines are developed by the use of killed virus. It is 
important to mention that different strains of NDV can cause different signs depending 
on the age of the host, susceptibility, and environmental stress, which can result in 
different rates of mortality and different levels of economic impacts. Mortality can be as 
high as 100% in velogenic NDV infections. The clinical signs of ND are not specific and 
can be associated with other diseases; clinical signs can range from depression and 
diarrhea, to a deterioration or cessation in egg production (Alexander and Senne, 2008).  
The purpose of vaccination is not only to generate a humoral immune response 
against a specific pathogen but also to establish cell-mediated immunity. In commercial 
poultry production, vaccination programs of breeder hens are intended to hyper 
immunize hens to allow for the passive transfer of immunity to the progeny which then 
is able to establish passive immunity from day of hatch (Qureshi et al., 1998b). It is 
important to mention that such vaccination regimens may vary from region to region of 
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the world as they are dependent upon the type of breeder hen and, very importantly, on 
the endemic diseases and current immunological challenges present in that particular 
region.  
Additionally, it is important to mention that in order to maximize immunological 
benefit by assuring proper function of the vaccines they have to be delivered properly 
and effectively. It is also imperative to understand that the immunological response may 
vary depending on the nature of the challenge or infection. In modern poultry, the 
efficacy of vaccines and the health of any flock at any given time are directly related to 
management practices.  
2.2 Avian Adaptive Immune System   
The avian immune system has been characterized for being functionally and 
structurally complex. It is very clear that in commercial poultry production its 
performance, establishment and development is undoubtedly influenced by genetic, 
nutritional, and environmental factors that allows it to be a sensitive and very important 
gauge of management practices on avian health and as a result on production 
performance (Qureshi et al., 1998b). 
 The importance of understanding the mechanisms in which the adaptive immune 
system works in order to combat pathogens commonly found in a commercial poultry 
setting forms the basis of any plan that aims to maintain animal health and economic 
feasibility in a commercial setting. The immune system of birds is divided into innate 
and adaptive immunity where the innate immune system has low specificity with no 
memory and in contrast the adaptive immune system has high specificity, develops 
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immunological memory and it often times provides life-long protection against a 
previously encountered pathogen (Davidson et al., 1996). Even though the adaptive 
immune system is quite different from the innate immune system, both components are 
intrinsically connected and are fundamentally important for the generation of effective 
immune responses. Innate immune responses are primarily mediated by cells such as 
macrophages and natural killer cells that can prevent the growth and replication of an 
antigen source or, if required, initiate a cascade of events that will trigger an adaptive 
immune response. 
 The correct processing and presentation of an antigen is essential for the optimal 
development and establishment of an adaptive immune response and it constitutes the 
beginning of the latter response. It is important to mention that the cellular components 
of blood including red blood cells, platelets, and white blood cells have the same 
precursor cells; it is because hematopoietic stem cells located in the bone marrow have 
the ability to generate any cellular component of blood they are often referred to as 
pluripotent hematopoietic stem cells (Janeway et al., 1999). 
 An important distinction is made when the pluripotent hematopoietic stem cells 
generate stem cells with a more limited potential and those stem cells become the 
immediate creators of red blood cells and the two types of white blood cells (Janeway et 
al., 1999).  The stem cells which give origin to the two types of white blood cells are 
myeloid and lymphoid stem cells. The myeloid stem cells give origin to multiple 
important cells like macrophages, dendritic cells, and granulocytes. All these cells play 
essential roles in the immune system.  
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Macrophages, which are part of the mononuclear phagocytic system play an 
essential role in both adaptive and innate immune responses and are part of the first line 
of defense against microbial infections (Qureshi and Miller, 1991). Macrophages are the 
mature form of monocytes which are constantly circulating in the blood. When they 
migrate into the tissue they become macrophages capable of killing bacteria and tumor 
cells; they perform phagocytosis like dendritic cells which are essential cells that can 
phagocytose, be macropynocytic, and present antigens to lymphocytes (Janeway et al., 
1999). In addition to macrophages being phagocytic as well as bacteriostatic, chicken 
macrophages are highly bactericidal as they are capable of killing more than 80% of 
internalized Salmonella in the first 15 min of engulfment (Qureshi et al., 1998b). 
Macrophages are also capable of producing numerous types of cytokines and 
chemokines.  
Cytokines produced by cells that belong to the immune system receive the name 
of leukocytic cytokines and they serve as regulators of the immune responses and can 
have several effector functions on many cells. For instance, macrophages following 
activation secrete Interleukin-1, which is a proinflammatory cytokine. Its effector 
mechanism may result in activation, deactivation, cell death, anabolism, catabolism, 
chemotaxis, migration inhibition, or differentiation (Qureshi, 1998a).  
Interferon gamma is a cytokine produced predominantly by natural killer cells 
upon activation of an innate immune response and by CD4 and CD8 T-cells as part of 
the activation of the adaptive immune system. Interferon gamma is an extremely 
important cytokine with immunostimulatory and immunomodulatory effects on the 
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entire immune system that among many different effector mechanisms, it can inhibit 
viral and intracellular bacterial infections, control tumor development by enhancing their 
immunogenicity and very importantly, it can activate macrophages, an important cell in 
both innate and adaptive immunity (Schoenberg and Wilson, 2007).  
The adaptive immune system relies on many different cells and effector 
mechanisms that provide the host organism with a complex defense system against 
innumerable pathogens. It can do all this by utilizing many effector mechanisms and 
cells like the B or T lymphocytes. B cells when stimulated differentiate into plasma cells 
that secrete antibodies that are highly specific towards an antigen and are able to combat 
pathogens (Davidson et al., 1996). T-cells are able to react and destroy host cells that 
have been invaded by pathogens (Davidson et al., 1996).  
The lymphoid stem cell originated from pluripotent hematopoietic stem cells 
gives rise to both B-lymphocytes and T lymphocytes (Janeway et al., 1999). These two 
major types of lymphocytes mature in the primary lymphoid organs thymus and bursa of 
Fabricius. The T-lymphocytes mature in the thymus and B lymphocytes in the bursa of 
Fabricius. The adaptive immune system can be divided into humoral immune responses, 
which relies on antibodies to combat extracellular pathogens, or cell-mediated immune 
responses, which rely on T-cells and cytokines in order to respond to intracellular 
pathogens (Kapczynski, 2013).  
The humoral immune arm of the adaptive immune system relies on the ability of 
antibodies to interact with extracellular antigens which results in the activation of 
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effector mechanisms, for example phagocytosis or activation of the classical pathway of 
the complement system which results in the elimination of antigen (Erf, 2004).  
 Moreover, the ability of antibodies to activate natural killer cells (NK) by 
forming a bridge between infected cells expressing antigens and killer cells through the 
bonding of the Fc region on the antibodies with Fc receptors on killer cells allows the 
organism to ensure the elimination of infected cells in a cellular mechanism known as 
antibody-dependent cellular-cytotoxicity (Abbas et al., 2000). Most immune responses 
that fall into the adaptive immune system are triggered when T cells in circulation are 
able to identify its specific antigen on the surface of a dendritic cell found on peripheral 
lymphoid tissues which include spleen, lymph nodes, and mucosal associated lymphoid 
tissues which are constantly collecting antigens from the epithelial surfaces of the 
tissues. The constant collection of antigen and its further presentation to specialized cells 
that many organisms exposed to a direct stimulus in any lymphoid organ experience can 
result in alterations in immune system functions. This direct tropism often times results 
in organ necrosis or loss of function; it can result in specific lymphocyte subpopulations 
to be affected (Qureshi et al., 1998b). 
2.3 Immunoassays 
A substantial development on the amount of immunoassays that one can utilize 
in order to study the responses generated by the immune system of any organism has 
been advanced throughout the years. Among the many different types of immunoassays 
that are used to measure cell-mediated immune responses, the most valuable is possibly 
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flow cytometry because of its ability to identify and quantify in a rapid manner 
functional subpopulations of cells in a heterogeneous cell culture.  
The use of flow cytometry provides valuable information like quantification of 
cytokines from a specific cell type in a heterogeneous cell population (Jung, 1993). Flow 
cytometry is a valuable technique that allows for rapid measurements of cells as they 
pass in a fluid stream one by one through a sensing laser. One could argue that the most 
notable advantage about flow cytometry is that it provides measurements from each cell 
within a heterogeneous suspension and not just an average value of the whole 
population. Because of its ability to measure multiple cell parameters using fluorescence 
and light scatter, flow cytometry’s applications in research and medicine are 
innumerable. The ability of flow cytometry to study individual types of cells via cell 
sorting allows quantifying, studying, and identification of specific functional 
subpopulations of cells quickly and reliably; making it ideal for the study of cell-
mediated immune responses for example.  
Other common tools used to measure immune responses include enzyme-linked 
immunoassay (ELISA), detection of cytokines like interferon gamma, which plays an 
important role in the activation of cell-mediated immunity, and use of sandwich ELISA 
(Bercovici, 2000).  
2.4 Saccharomyces cerevisiae  
The benefits of non-pathogenic yeast Saccharomyces cerevisiae as a growth 
promoter in the animal industry are very well documented. Yeast products are regarded 
as a viable alternative for the use of antibiotics in the poultry industry due to their 
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modulating ability in the immune system as they can activate the immune system and 
provide competitive binding sites for pathogenic bacteria (Gao et al., 2008). 
 In the poultry industry, Saccharomyces cerevisiae has received a lot of interest 
throughout the years and it has been the subject of many research programs and has been 
used among many other areas as a way to improve immune response, protect against 
aflatoxicosis, enhance intestinal health, and as a replacement strategy for the use of 
antibiotics in the poultry industry. 
 Stanley et al., (1993) reported the benefits of Saccharomyces cerevisiae, which 
included restoring to control levels the activities of the enzymes alamine transaminase 
and creatine phosphokinase, as well as having a positive effect on mean body weights of 
chicks fed aflatoxin-contaminated feed. It has been reported that yeast could be a 
potential strategy in the replacement of antibiotic-based drugs in feed of broiler chicks in 
chicken houses with new litter (Hooge et al., 2003) or in houses with recycled litter 
(Stanley et al., 2004).   
The inclusion of yeast culture residue derived from Saccharomyces cerevisiae 
has been found to be useful in controlling intestinal coliforms and, to some extent, 
coccidial oocysts as well as in effecting growth rate in broiler chickens on recycled litter 
using a rapid turnover schedule (Stanley et al., 2004).  
The effector mechanisms and effects of Saccharomyces cerevisiae on other 
animals have been studied and are widely reported in the literature. Van der Peet-
Schwering et al., (2007) reported that weanling piglets fed Diamond V XPCLS 
(Diamond V Mills, Cedar Rapids, IA) improved their feed efficiency and growth rate in 
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comparison to control groups and these effects were comparable to those from 
Avilamycin-fed piglets. The supplementation of Saccharomyces cerevisiae in laying 
hens has also been reported in the literature, and it has been shown to improve 
phosphorus utilization, feed efficiency, and egg quality (Tangendjaja and Yoon, 2002). 
 Multiple mechanisms in which yeast can have an effect on the immune system 
have been intensely studied and it has recently been suggested by Alizadeh, (2016) that 
yeast cell wall products can stimulate the expression of pattern recognition receptors and 
are able to maintain an immune homeostasis through the regulation of inflammatory 
activities. 
Morales-Lopez and Brufau, (2013) reported a positive effect of yeast cell wall on 
feed efficiency in chickens predominantly under conditions of an immunological 
challenge. The report also suggested that inclusion of yeast cell wall in the diets of 
broilers may avoid the reduction of the bursa of Fabricius caused by a challenge with 
Escherichia coli lipopolysaccharide by helping them increase tolerance to microbial 
challenge.  
The number of Saccharomyces cerevisiae derived products is considerable and 
the development of more products as well as more research has evolved recently. 
However, the need to keep studying yeast products is still highly relevant as its mode of 
action has not been completely identified, nor the extent of its immunomodulatory 
capacities.  
It is important to mention that not all Saccharomyces cerevisiae derived products 
are the same. Thus, their positive effects can vary significantly. Some products are 
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primarily cell walls and others like XPC, are a mixture of a fermentation product and 
yeast components. More information about XPC can be found in the Appendix section.  
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3. THE EFFECT OF XPC™ SUPPLEMENT IN DIET ON EARLY 
DEVELOPMENT OF ADAPTIVE IMMUNE RESPONSE IN BROILERS 
  
 
3.1 Introduction 
The poultry industry is currently searching for new strategies to maintain 
production levels while eliminating the use of antibiotics and maintaining bird health. 
Our lab as a potential strategy to enhance immune function and poultry health has 
identified the functional metabolites of a Saccharomyces cerevisiae fermentation 
product, Diamond V Original XPC
TM
 (XPC). The overall goal of this study was to 
evaluate the effect of dietary XPC supplementation on the early development of the 
adaptive immune response in broilers in response to a live attenuated NDV vaccine. 
A total of 240 one-day old Ross 308 broilers were randomly assigned to one of 
two diets: 1) XPC, 2) control group. Both treatments consisted of 4 pens per diet and 30 
birds per pen. Antigen-specific humoral immune response was assessed by NDV-
specific IgY using ELISA on days 4, 7, 14, 21, 24, 28, 35, and 42. Feed conversion ratio, 
feed consumption, and body weights were also assessed. Cumulative feed conversation 
ratio, body weights, and feed consumption were calculated.  
In a previous experiment conducted in our lab using B1 strain NDV vaccine as 
primary immunization, Park et al., (2014), we observed a strong antigen-specific 
humoral immune response following secondary immunization with live LaSota strain 
NDV vaccine in both control and XPC birds. However, XPC birds reached a peak NDV 
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specific humoral immune response by day 28, 7 days earlier than control birds. All 
antibody titers were in response to a live attenuated NDV vaccine and not infection. 
In the current experiment, we observed an establishment of NDV specific 
humoral immune response by day 28 on both dietary treatments in contrast to a previous 
experiment, Park et al., (2014). However, we observed a humoral immune response with 
slower decaying of NDV-specific antibodies in XPC supplemented birds. This leads us 
to believe that the difference in humoral response between this experiment and our 
previous data could be a result of interference by maternal antibodies.  
3.2 Materials and Methods  
With the intention to have a better understanding of previous results obtained in 
our lab involving the immunomodulatory capacity on the adaptive immune system of 
broilers fed XPC, several immune parameters were measured. The present experiment 
studied the overall NDV-specific antibody serum IgY titers of broilers throughout the 
duration of the trial and measured immune-associated parameters in early stages of 
immune system development (day 4 and 7 post-hatch) as well as earlier post-boost (day 
24 instead of day 28). Differences in the development of cell-mediated immunity were 
also measured. Birds were housed at the Texas A&M University Poultry Research, 
Teaching and Extension Center (TAMUPRC) located in College Station, TX.  
A total of 240 one-day old broiler chicks Ross 308 type were randomly assigned 
to either a control diet (120 broiler chicks) or XPC supplemented diet (120 broiler 
chicks). XPC was included into treatment diet at 1.25 kg/metric ton for starter, grower 
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and finisher diets. Feed was stored in plastic lined 30 gallon barrels labeled with date, 
diet, treatment code and experiment identification number.  
Starter (0-14d), grower (15-28d), and finisher (29-42d) diets were manufactured 
at TAMUPRC feed mill. Feed and water were provided ad libitum during the entire trial. 
A 2x batch of the control diet was mixed and split into two equal parts prior to pelleting. 
The control feed was pelleted and placed in barrels. The treated feed was returned to the 
mixer and an appropriate amount of XPC was added and allowed to mix for 10 minutes 
prior to pelleting and storage in barrels. Composite feed samples from each feed mixing 
were collected and stored at -20
o
C until submitted for proximate analysis. The 
experimental design consisted of 8 pens, 4 pens per diet. All diets had a corn/soybean 
meal base (Table 1).  
On day one, chicks in the vaccinated group received oculo-nasally live B1 strain 
NDV vaccine (USDA Product code: 1711.10; Merial Select Laboratories, Gainesville, 
Georgia) followed by live LaSota strain NDV vaccine (USDA Product code: 1721.11; 
Merial Select Laboratories, Gainesville, Georgia) at day 21 administered via the ocular-
nasal route. The level of NDV-specific IgY was measured by ELISA on days 1, 4, 7, 14, 
21, 24, 28, 35, and 42 using a Newcastle Disease Antibody Test Kit (Synbiotics Corp., 
San Diego, CA) to monitor the humoral immune response. The average of positive and 
normal control serum absorbance was calculated. Each blood sample collected was 
examined; the antibody titers were calculated using the formula: S/P (Sample to positive 
ratio) = (Absorbance of sample – Average of N control absorbance)/ (Average of positive 
control absorbance – Average of N control absorbance). The final titer was calculated based 
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on the following formula provided in manufacturer’s instructions: Final Titer = ANTILOG 
(1.464 x (Log10S/P) + 3.740). 
Blood samples (0.5ml) were obtained by venipuncture. Cumulative feed 
conversion ratio, feed consumption as well as body weights were recorded from all 
treatments. 
Because a strong adaptive immune system involves both effective humoral and 
cell-mediated immune responses, the effect of XPC on vaccine-induced cell-mediated 
immunity was evaluated by obtaining peripheral blood leukocytes. 0.5ml of blood 
samples were collected from the wing by venipuncture from each group and transferred 
to heparinized tubes on day 7 (n=5 birds from each dietary treatment) and 24 (n=5 birds 
from each dietary treatment) post-immunization.  
 The subpopulation of CD4+ (T-helper cell) and CD8+ (T-cytotoxic cells) T 
lymphocytes in peripheral blood of control and XPC groups served as the immune-
competence indicator of the adaptive immune response. The non-coagulated blood 
samples were diluted with PBS in a 1:1 ratio and 6 ml of diluted blood was carefully 
layered onto 6 ml of Histopaque 1077 medium (Sigma, St. Louis, MO.) per the 
manufacturer’s instructions.  
 Lymphocyte subpopulations were measured using flow cytometry on day 7 and 
24. Peripheral blood leukocytes were used for peripheral lymphocyte subset analysis. 
Cells were blocked with mouse whole IgG (Jackson ImmunoResearch, West Grove, PA) 
to block Fc receptors. Four-color immunostaining was performed. Blocked cell 
suspensions were incubated with FITC-conjugated-anti-CD3, R-PE-conjugated anti-
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CD4, Cy5-conjugated anti-CD8, and biotinylated anti-Bu-1. The detection of 
biotinylated-anti-Bu-1 was performed by incubation with quantum-red labeled 
streptavidin. After washing and fixation, the cell suspensions were analyzed at the Texas 
A&M College of Medicine-Cell Analysis Facility and data were analyzed using Flowjo 
software (Flowjo LLC, Ashland, OR.). 
 An important interaction that occurs as part of the adaptive immune response is 
the interaction between follicular T-helper cells and B cells in the spleen. This 
interaction is of importance as it has a major effect on the development of antigen-
specific B-cell responses during vaccination. From each group, 5 birds were euthanized 
by CO2 asphyxiation for the collection of splenocytes. Single-cell splenocyte 
suspensions were obtained by pushing the spleen through a 70-μm cell strainer (BD 
Falcon, Franklin Lakes, NJ). Splenocytes were used for splenic lymphocyte subset 
analysis. Cells were blocked with mouse whole IgG (Jackson ImmunoResearch, West 
Grove, PA) to block Fc receptors. Four-color immunostaining was performed. Blocked 
cell suspensions were incubated with FITC-conjugated-anti-CD3, R-PE-conjugated anti-
CD4, and Cy5-conjugated anti-CD8, and biotinylated anti-Bu-1. The detection of 
biotinylated-anti-Bu-1 was performed by incubation with quantum-red labeled 
streptavidin. After washing and fixation, the cell suspensions were analyzed at Texas 
A&M College of Medicine-Cell Analysis Facility and data was analyzed using Flowjo 
software. 
  No drug therapy was used during the study. When any study personnel entered a 
pen (i.e., to collect birds for study procedures), plastic boots and gloves were utilized. 
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The plastic boots and gloves were removed by the person who was inside the pen as they 
stepped out to avoid cross-contamination throughout the facility. Plastic boots and 
plastic gloves were discarded in an appropriate container after use. 
All pens were monitored three times daily for general flock condition, 
temperature (recorded on log sheets), lighting, water, feed, litter condition, and 
unanticipated house conditions/events. Findings were documented on log sheets. 
Mortality was monitored in each pen daily. 
Statistical analysis was completed with the SAS (SAS Institute, Cary, NC) 
statistical software package. All data were analyzed via one-way ANOVA using the 
GLM procedure. Differences were deemed significant at P<0.05 and means were 
separated by the PDIFF procedure. All animal handling and care practices were in 
accordance with an approved animal use protocol, IACUC 2014-0017 reference number 
047580. 
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Table 1 Experiment 1 - Experimental diets and nutrient composition 
 Starter 
0-14 d 
Grower 
15-28 d 
Finisher 
29-42 d 
Ingredients, %    
       Corn, yellow grain 58.46 64.73 68.53 
Soybean meal, dehulled 
solvent 
34.48 29.33 26.64 
Bio/Phos 16/21 P 1.56 1.59 1.29 
Limestone 1.49 1.46 1.60 
Salt, plain 0.51 0.49 0.46 
Mineral mix
1
 0.05 0.05 0.05 
DL Methionine 0.28 0.08 0.16 
Lysine 0.17 0.02 0.12 
Vitamin Premix
2
 0.25 0.25 0.25 
Fat A/V blend 2.75 2.00 2.90 
Original XPC
3
 0.125 0.125 0.125 
.12 
    Calculated Nutrient Composition   
CP, % 22.02 19.80 17.99 
ME, kcal/lb 3048 3055 3151 
Crude Fat, % 5.30 4.74 5.73 
Lysine, % 1.30 1.05 1.00 
Methionine (M), % 0.61 0.39 0.44 
M+Cysteine, % 0.97 0.72 0.75 
Tryptophan 0.26 0.23 0.20 
Threonine  0.82 0.74 0.67 
Arginine 1.45 0.74 1.14 
Valine, % 1.00 0.91 0.82 
Calcium, % 0.92 0.90 0.89 
Available Phosphorous, 
% 
0.45 0.45 0.38 
Sodium 0.22 0.21 0.20 
Chloride, % 0.39 0.34 0.35 
 
1
Vitamin premix added at this rate yields 11,023 IU vitamin A, 3,858 IU vitamin D3, 46 
IU vitamin E, 0.0165 mg B12, 5.845 mg riboflavin, 45.93 mg niacin, 20.21 mg d-
pantothenic acid, 477.67 mg choline, 1.47 mg menadione, 1.75 mg folic acid, 7.17 mg 
pyroxidine, 2.94 mg thiamine, 0.55 mg biotin per kg diet.  The carrier is ground rice 
hulls. 
2
Trace mineral premix added at this rate yields 149.6 mg manganese, 55.0 mg 
zinc, 26.4 mg iron, 4.4 mg copper, 1.05 mg iodine, 0.25 mg selenium, a minimum of 
6.27 mg calcium, and a maximum of 8.69 mg calcium per kg of diet. The carrier is 
calcium carbonate and the premix contains less than 1% mineral oil. 
3
XPC is Diamond V Original XPC (Cedar Rapids, Iowa); corn will replace XPC in 
control diet. 
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3.3 Results   
            Assessment of live production performance was measured using mean body 
weights and feed conversion ratio at day 42 as comparison parameters. Results of the 
effects of a diet containing XPC on body weights are summarized in Table 2. There were 
no significant differences in body weights or feed conversion (P>0.05) between the 
dietary treatments during the experimental period (1 to 42 d). Feed consumption and 
feed conversion results are summarized on table 3. No significant differences (P>0.05) 
in feed consumption were observed. 
 
Table 2 Experiment 1 - Effects of diet containing XPC on body weight (BW) 
  Diets
1
  
Day of age*  Control  
BW (g) 
XPC  
BW (g) 
SEM 
4 104.30 106.15 2.11 
7 179.65 178.65 4.15 
14 491.50 422.65 32.48 
21  944.00 907.15 25.59 
24 1132.10 1137.75 33.17 
28 1414.95 1393.60 11.84 
35 1963.85 1942.45 63.2 
42 2724.60 2621.00 36.35 
No significant differences were observed (P>0.05)  
* n= 15 birds per day, Ross 308. 
1 
Diets with no XPC served as Control and XPC diets had inclusion of 1.25 kg of 
Original XPC /metric ton  
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Table 3 Experiment 1 - Effects of a diet containing XPC on cumulative feed 
consumption and feed conversion ratio (FC) at day 42  
  Diets
1
  
Day of age*  Control  
Feed Consumption  
(g) 
XPC  
Feed Consumption  
(g) 
SEM 
14
2
 652.81 631.17 14.20 
28
3
 2488.18 2421.08 27.87 
42
4
 4938.83 4689.30 36.35 
FC at day 42 1.64 1.58 0.06 
No significant differences were observed (P>0.05)  
* n= 15 birds per day, Ross 308. 
1
Diets with no XPC served as Control and XPC diets had inclusion of 1.25 kg of 
Original XPC /metric ton  
2
End of starter diet; 
3
End of grower diet; 
4
End of finisher diet  
 
The results of the effect of XPC on serum levels of NDV-specific IgY are presented in 
table 4. There was no indication of a faster establishment of NDV-specific humoral 
immune response on XPC supplemented birds compared to the control group. The 
dietary control treatment achieved its peak NDV-specific humoral immune response on 
day 28, 7 days after the secondary immunization, as well as XPC supplemented birds 
which was only seen on treated birds in previous experiments by our lab. The differences 
observed on days 28 and 35 were not statistically significant (P>0.05) and a rapid 
decline of NDV titers was observed in the control group. However, on day 42 XPC 
supplemented birds had a significantly (P<0.05) higher NDV titer and a much slower 
decline of NDV-specific antibodies was observed following secondary immunization. 
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Table 4 Experiment 1 – Effect of XPC on mean anti-NDV titers (IgY) 
       Diets
1
  
Day of age*  Control   XPC   SEM 
4 4405.68 3424.53 581.65 
7 2798.41 3609.55 603.22 
14 857.37 865.01 254.97 
21 1251.64 682.99 261.74 
24 1100.88 1051.36 351.26 
28 2524.50 2198.61 406.29 
35 1596.19 2197.35 397.92 
42 1032.40
b
 2026.09
a
 381.55 
Shown in table are the calculated antibody titers (IgY) from the optical density measured 
by ELISA reader for the samples that were run through ELISA test specific for anti-
Newcastle disease (ND) virus IgY production. 
On day of hatch the level of NDV-specific maternal antibodies was calculated and 
determined to be 6886.58 
 a, b 
Means within a row lacking a common superscript differ significantly (P<0.05). 
Each value represents the mean value for each group.  
* n= 15 birds per day, Ross 308. 
1
Diets with no XPC served as Control and XPC diets had inclusion of 1.25 kg of 
Original XPC /metric ton  
 
Cell-mediated immunity was also measured during this trial. Results of peripheral 
lymphocyte and splenic lymphocyte subset analysis are summarized in table 5. On days 
7 and 24, cell-mediated immunity was measured via flow cytometry. There were no 
significant differences (P>0.05) observed between the dietary treatments on the same 
sampling day however, the percentage of CD3+, CD4+, and B-cells in the spleen were 
significantly (P<0.05) higher for both treatments on day 7 compared to day 24. Flow 
cytometry was conducted on peripheral blood leukocytes and it showed no significant 
differences (P>0.05) between the dietary treatments on the same sampling day. The 
number of CD3+ cells was significantly higher in both dietary treatments at day 7 
   25 
 
compared to day 24. B-cell population in circulation at day 24 was significantly (P<0.05) 
higher in the control group compared to both treatments at day 7. 
 
Table 5 Experiment 1 – Flow cytometry: Peripheral lymphocyte and splenic 
lymphocyte subset frequencies 
  Day of age   
 7 24  
 Diets
1
  
 Control * XPC * Control *  XPC * SEM 
Spleen      
(%) CD3+ 26.24
 a
 35.52
a
 9.69
b
 10.92
b
 3.15 
(%) CD4+ 18.64 22.38 25.24 26.04 3.07 
(%) CD8+ 23.62
a
 23.46
a
 13.96
b
 10.53
b
 1.90 
(%) Bu-1+  29.86
ab
 30.30
a
  19.18
ab
 17.29
b
 3.12 
Circulation      
(%) CD3+ 37.63
a
 34.31
a
  2.08
b
  2.71
b
 4.29 
(%) CD4+ 7.60 6.52 8.60 5.63 1.98 
(%) CD8+ 4.29 2.58 11.11 4.54 3.24 
(%) Bu-1+  1.54
a
  1.06
a
 14.81
b
    8.85
ab
 4.39 
a, b
 Means within a row lacking a common superscript differ significantly (P<0.05). 
Each value represents the mean value for each group.  
* n= 5 birds per day, Ross 308. 
1
Diets with no XPC served as Control and XPC diets had inclusion of 1.25 kg of 
Original XPC /metric ton  
 
3.4 Discussion  
The overall goal of this study was to evaluate the effect of dietary XPC 
supplementation on the early development of the adaptive immune response in broilers. 
Live production performance results showed no significant differences (P>0.05) between 
the dietary treatments in body weights, feed consumption or feed conversion ratio during 
the experimental period (1 to 42d). The feed conversion ratio showed a tendency to 
improve in the XPC group and on day 42 a lower feed conversion ratio was observed. 
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These results are in agreement with Alizadeh et al., (2016) where yeast-derived products 
were utilized as a dietary treatment, and it was reported that diets containing yeast-
derived product tended to improve feed conversion ratio compared to the control group.  
Morales-Lopes and Brufau (2013) showed that supplementation with 
Saccharomyces cerevisiae cell walls did not result in any significant differences in feed 
intake, body weight gain but feed conversion ratio on days 21 and 28 were better 
compared to the control group. Gao et al., (2008) reported that dietary supplementation 
of yeast culture, Diamond V XP (Yeast Culture), at appropriate levels resulted in 
improved average daily gain and feed conversion in broilers. Some studies have had 
similar results to the present experiment.  
It has been reported in the literature that birds receiving yeast-derived products 
tend to have an improvement in feed conversion ratio; Ghosh et al., (2012) suggested as 
well as Jung and Batal (2012) that the effector mechanism of these products is the result 
of an establishment of gut development and exclusion of pathogenic bacteria. This 
experiment did not monitor gut development or presence of pathogenic bacteria in the 
broilers utilized. 
In this experiment, the establishment of cell-mediated immunity was measure on 
days 7 and 24. Cell-mediated immune response following NDV infection can be 
detected as early as two or three days after infection (Ghumman et al., 1976). There were 
no significant differences (P>0.05) observed between the dietary treatments on the same 
sampling day however, CD3+, CD4+ and B-cell populations on the spleen were 
significantly (P<0.05) larger in both treatments on day 7 compared to day 24. Flow 
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cytometry on peripheral blood leukocytes did not show significant differences (P>0.05) 
between the dietary treatments in the same sampling day. CD3+ was significantly higher 
on both dietary treatments at day 7 compared to day 24. B-cell population in circulation 
at day 24 was significantly (P<0.05) higher in the control group compared to both 
treatments at day 7. Overall, a higher percent of lymphocytes in circulation and spleen 
was observed on day 7 compared to day 24, three days after the secondary 
immunization. Lambrecht et al., (2004) compared NDV obtained from chicken 
splenocytes that received live or inactivated NDV vaccines and reported an increased 
cell-mediated immune response with the live NDV vaccination. However, no stimulation 
of cell-mediated immunity was observed in this experiment following the secondary 
immunization with live LaSota strain NDV vaccine.  
Protection by NDV-specific antibodies has been reported throughout the 
literature to be fundamental against a live NDV challenge. In birds, measurements of 
antibody responses have been used to analyze their humoral immune status (Sklan et al., 
1994). Gao et al., (2008) reported a linear increase in NDV antibody titers when the 
level of yeast extract fed to birds increased and suggested its potential modulation of 
humoral immunity. During the entirety of this experiment, a thorough monitoring of 
NDV-specific humoral immune response was conducted. In immature chickens, 
immunoglobulin Y is the functional homolog to immunoglobulin G found in humans 
and is considered the major antibody in blood circulation as well as an important 
activator of the classical complement system, which is involved in pathogen elimination 
(Larsson et al., 1993). Saccharomyces cerevisiae has been identified in multiple 
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literature reviews as an effective modulator of the immune system capable of reducing 
susceptibility of animals to infections. Ghosh et al., (2012) reported that Saccharomyces 
cerevisiae had a beneficial impact on the humoral immune response against Newcastle 
disease in broilers.   
The ELISA results obtained from this experiment did not show any significant 
difference between the treatments until day 42. It was hypothesized based on a previous 
experiment by our lab, Park et al., (2014), that XPC supplemented birds are able to 
establish a faster antigen-specific humoral immune response, 7 days after receiving a 
secondary-immunization, compared to control birds. However, both dietary treatments 
achieved a fast-acquired humoral immune response. A significant difference in NDV 
titers between the dietary treatments was not observed until day 42 when XPC 
supplemented birds reached a significantly (P<0.05) higher NDV titer level.   
The acquired humoral immune response observed in XPC supplemented birds 
not only resulted in a significantly (P<0.05) higher NDV titer level at day 42. It also 
remained at a high titer level from day 28 until day 42, which could indicate that the rate 
of decay of the acquired protective antibodies against NDV was slower than the one 
observed in the control treatment. These results could be the indication that the immune 
function of broilers was modified by XPC during this trial. It has been reported by Gao 
et al., (2008) that immune function can be modified with dietary yeast culture 
supplementation. 
The ELISA results observed in this experiment suggest that the level of maternal 
antibodies could have influenced the extent or origin of the potential immunomodulatory 
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capacity of XPC. There are no current reports in the literature with similar results on 
acquired humoral NDV response or the influence of maternal antibodies on the effect of 
XPC in broilers. Cell-mediated immunity development in both dietary treatments was 
minimal following secondary immunization at day 21. None of the two dietary groups 
established a high cell-mediated immune response on day 24 compared to day 7. Despite 
the lack of cell-mediated immune response in both dietary treatments a robust humoral 
immune response was observe in both dietary treatments following the secondary 
immunization. 
3.5 Conclusion 
The results observed in this trial are different from those observed in a previous 
experiment conducted in our lab by Park et al., (2014). The results show XPC 
supplemented birds did not establish a faster NDV-specific humoral immune response 
than control birds like it was observed in our previous experiment; however, both groups 
achieved their highest NDV-titer at day 28, 7 days after the secondary immunization. 
XPC supplemented birds reached a significantly (P<0.05) higher NDV-specific humoral 
immune response on day 42.  
The observed NDV-specific humoral immune response on birds receiving XPC 
as a dietary treatment indicates that XPC could have modulated the adaptive immune 
system and as a result it established a different response that allowed them to have NDV-
specific antibodies for a more extended time. The achievement of a robust antigen-
specific humoral immune response in combination with a prolonged presence of 
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antibodies in circulation represent an excellent defense mechanism and a desired 
modulation of the development of the adaptive immune system by the poultry industry. 
  No significant differences (P>0.05) in the development of cell-mediated 
immunity were observed between the treatments on the same sampling day. The absence 
of cell-mediated immune response following a secondary immunization at day 21 in 
addition to the development of a strong humoral immune response in both dietary 
treatments could indicate that the mechanism of replication and infection of live NDV 
LaSota strain virus may be moving faster than expected; its presence in the spleen and 
circulation could be developing prior to 3 days post-secondary immunization. 
Despite the absence of a faster establishment of antigen-specific humoral 
immune response in treated birds there was a noticeable effect that resulted in a slower 
decay of NDV-specific antibodies which represents a more robust and protective 
humoral immune response compared to control birds. 
In this experiment, XPC supplemented birds did obtain a significant difference in 
live performance compared to birds fed a control diet. However, feed conversion ratio at 
day 42 was better in XPC treatment compared to the control treatment. Multiple reports 
in the literature like Gao et al., (2008); Alizadeh et al., (2016); Morales-Lopes and 
Brufau, (2013) have shown similar results with the use of comparable products. 
A considerable difference existed in the level of maternal antibodies on birds 
from experiment one compared to the level observed in our previous experiment where a 
faster establishment of NDV-specific humoral immune response was observed in XPC 
supplemented birds. The difference in maternal antibodies leads us to believe that 
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maternal antibodies could be influencing the extent of XPC’s modulation on the adaptive 
immune system and combined with NDV LaSota strain could also influence its 
development post-secondary immunization.  
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4. EVALUATION OF THE IMPACT OF LIVE LASOTA NEWCASTLE 
DISEASE VIRUS VACCINE ON EARLY DEVELOPMENT OF HUMORAL 
AND CELL-MEDIATED IMMUNE RESPONSE IN BROILERS 
 
4.1 Introduction 
Newcastle Disease (ND) has been a major problem in the poultry industry 
primarily because of its worldwide distribution and economic impact. Thus, multiple 
strategies exist to combat this disease, which can be effectively managed with good 
biosecurity programs and effective vaccination programs. The purpose of vaccination is 
not only to generate humoral immune response against a specific pathogen but also to 
establish cell-mediated immunity.  
The main objective of this experiment was to evaluate the impact of a 1x dose of 
live LaSota strain Newcastle Disease Virus vaccine administered ocular-nasal on days 0 
and 21 on early development of humoral and cell-mediated immune response in broilers 
and analyze the impact of this immunization schedule on the immunomodulatory 
capacity of Diamond V Original XPC
TM 
(XPC). We hypothesized that the use of a more 
virulent lentogenic strain of NDV vaccine at day 1 could aid in a faster establishment of 
antigen specific humoral response without compromising the development of NDV 
specific adaptive immunity and possibly potentiate the immunomodulatory effect of 
XPC on broilers. 
 A total of 640 Ross 308 broilers were randomly assigned to one of two 
treatments: 1) vaccinated, 2) unvaccinated, control group. Both groups will have 320 
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birds each. Each group will be further assigned to one of two treatments either 
supplemented with XPC or control diet. Spleen and bursa samples were excised for 
organ index analysis.  
Cumulative feed conversation ratio and body weights were measured. The level 
of NDV specific IgY was measured by ELISA which was evaluated on days 4, 7, 14, 21, 
24, 28, 35, and 42. Remarkably, no humoral response was established after receiving the 
booster (day21-42). Spleen index of the vaccinated group was significantly lower than 
control which is consistent with the ELISA data. The levels of interferon gamma in the 
circulation and in the spleen were measured on days 7 and 24. The results show 
considerably low amounts of detectable interferon gamma present in the circulation and 
secreted by splenocytes.   
Altogether, the results indicate that the use of a more virulent strain of NDV 
vaccine before the immune system develops could compromise the establishment of 
NDV specific adaptive immunity and it seems to have a detrimental effect on the 
modulation and establishment of adaptive immunity in XPC birds. 
4.2 Materials and Methods  
The main objective of this trial was to evaluate the impact of a 1x dose of live 
LaSota strain NDV vaccine administered oculo-nasally on days 1 and 21 on early 
development of humoral and cell-mediated immune responses in broilers. In addition to 
the main objective, a secondary purpose was to analyze the impact of this immunization 
schedule on the immunomodulatory capacity of XPC. Based on previous data obtained 
in our lab, Park et al., (2014), we identified that B1 strain NDV vaccine provides a 
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strong antigen-specific humoral immune response, and when used as primary 
immunization on birds fed a control diet it will result in birds reaching peak NDV-
specific humoral immune response by day 35.  
In a previous experiment using B1 strain NDV vaccine as primary immunization, 
Park et al., (2014), we observed a strong antigen-specific humoral immune response 
following secondary immunization with live LaSota strain NDV vaccine in both control 
and XPC birds but XPC birds reaching a peak NDV specific humoral immune response 
by day 28, 7 days prior to control birds.  
A total of 640 one-day old Ross 308 broilers were randomly assigned to one of 
two groups of 320 birds each: 1) vaccinated, 2) unvaccinated, control group. Each group 
was further assigned to one of two treatments either supplemented with XPC or control 
diet. The vaccinated birds received a live LaSota strain NDV vaccine (USDA Product 
code: 1721.11; Merial Select Laboratories, Gainesville, Georgia) at day 1 and 21. XPC 
was included into treatment diet at 1.25 kg/metric ton for starter, grower and finisher 
diets. Feed was stored in plastic lined 30 gallon barrels labeled with date, diet, treatment 
code and experiment identification number.  
All diets had a corn/soybean meal base (Table 6). Starter (0-14d), grower (15-
28d), and finisher (29-42d) diets were manufactured at TAMUPRC feed mill. Feed and 
water was provided ad libitum during the entire trial. A 2x batch of the control diet was 
mixed and split into two equal parts prior to pelleting. The control feed was pelleted and 
placed in barrels. The treated feed was returned to the mixer and an appropriate amount 
of XPC was added and allowed to mix for 10 minutes prior to pelleting and storage in 
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barrels. Composite feed samples from each feed mixing were collected and stored at -
20
o
C until submitted for proximate analysis. Each group with its treatment had a 
replicate pen for a total of 16 pens.  
 Spleen and bursa samples were excised for organ index analysis on days 4, 7, 14, 
21, 24, 28, 35. Chickens were weighed prior to euthanasia by CO2 asphyxiation. Spleen 
and bursa of Fabricius from each group were harvested and weighed to determine organ 
indexes, defined as organ weight/body weight ratio. 
Cumulative feed conversion and feed consumption of all treatments were 
calculated during each dietary phase (1-14d, 15-28d, 29-42d) and body weights were 
obtained from all treatments as well. 
 As previously described, a strong adaptive immune system involves both an 
effective humoral and cell-mediated immune responses. The effect of XPC on vaccine-
induced cell-mediated immunity was evaluated by obtaining peripheral blood 
leukocytes. 0.5ml of blood samples were collected from the wing by venipuncture from 
vaccinated groups only and transferred to heparinized tubes on day 7 (n=5 birds from 
each dietary treatment) and 24 (n=5 birds from each dietary treatment) post-
immunization.  
 The subpopulation of CD4+ (T-helper cell) and CD8+ (T-cytotoxic cells) T 
lymphocytes in peripheral blood of control and XPC groups served as the immune-
competence indicator of the cell-mediated immune response. The non-coagulated blood 
samples were diluted with PBS in a 1:1 ratio and 6 ml of diluted blood was carefully 
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layered onto 6 ml of Histopaque 1077 medium (Sigma, St. Louis) per the manufacturer’s 
instructions. 
  Lymphocyte subpopulations were measured using flow cytometry on day 7 and 
24. Peripheral blood leukocytes were used for peripheral lymphocyte subset analysis. 
Cells were treated with mouse whole IgG (Jackson ImmunoResearch, West Grove, PA) 
to block Fc receptors. Four-color immunostaining was performed. Blocked cell 
suspensions were incubated with FITC-conjugated-anti-CD3, R-PE-conjugated anti-
CD4, and Cy5-conjugated anti-CD8, and biotinylated anti-Bu-1. The detection of 
biotinylated-anti-Bu-1 was performed by incubation with quantum-red labeled 
streptavidin. After washing and fixation, the cell suspensions were analyzed at the Texas 
A&M College of Medicine-Cell Analysis Facility and data was analyzed using Flowjo 
software (Flowjo LLC, Ashland, OR.). 
 Interferon Gamma release by T-cells after in vitro stimulation has been used as 
an efficient way to evaluate cell-mediated immunity in the chicken after vaccination. 
Splenocytes and peripheral blood leukocytes harvested at 7 and 24 days of age were 
used in this assay. Combined with flow cytometry data, this provided us with valuable 
information about the activation status of the T-lymphocytes. Interferon Gamma secreted 
by splenocytes was measured by sandwich ELISA on day 7 and 24.  
 The level of NDV-specific IgY was measured by ELISA on days 4, 7, 14, 21, 24, 
28, 35, and 42 using a Newcastle Disease Antibody Test Kit (Synbiotics Corp., San 
Diego, CA). The average of positive and normal control serum absorbance was 
calculated. The antibody titers were calculated using the formula: S/P (Sample to 
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positive ratio) = (Absorbance of sample – Average of N control absorbance)/ (Average 
of positive control absorbance – Average of N control absorbance). The final titer was 
calculated based on the following formula provided in manufacturer’s instructions: Final 
Titer = ANTILOG (1.464 x (Log10S/P) + 3.740). 
 An important interaction that occurs as part of the adaptive immune response is 
the interaction between follicular T-helper cells and B cells in the spleen. This 
interaction is of importance as it has a major effect on the development of antigen-
specific B-cell responses during vaccination. From each group, 5 birds were euthanized 
by CO2 asphyxiation for the collection of splenocytes. Single-cell splenocyte suspension 
was obtained by pushing the spleen through a 70-μm cell strainer (BD Falcon, Franklin 
Lakes, NJ). Splenocytes were used for splenic lymphocyte subset analysis. Cells were 
treated with mouse whole IgG (Jackson ImmunoResearch, West Grove, PA) to block Fc 
receptors. Four-color immunostaining was performed. Blocked cell suspensions were 
incubated with FITC-conjugated-anti-CD3, R-PE-conjugated anti-CD4, and Cy5-
conjugated anti-CD8, and biotinylated anti-Bu-1. The detection of biotinylated-anti-Bu-1 
was performed by incubation with quantum-red labeled streptavidin. After washing and 
fixation, the cell suspensions were analyzed at Texas A&M College of Medicine-Cell 
Analysis Facility and data was analyzed using Flowjo software. 
Blood samples were obtained on days 4, 7, 14, 21, 24, 28, 35, and 42 by 
venipuncture; 0.5ml blood samples were collected. NDV-titers were obtained and 
calculated as described by the manufacturer. The measurement of all these parameters 
aimed to evaluate the impact of a more virulent strain of NDV vaccine on the 
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establishment of NDV specific adaptive immunity and to analyze the immune response 
generated by broilers supplemented with XPC.  
No drug therapy was used during the study. When any study personnel entered a 
pen (i.e., to collect birds for study procedures), plastic boots and gloves were utilized. 
The person who was inside the pen as they stepped out to avoid carrying over any fecal 
material throughout the facility removed the plastic boots and gloves. Plastic boots and 
plastic gloves were discarded in an appropriate container after use.  
All pens were monitored three times daily for general flock condition, 
temperature (recorded on log sheets), lighting, water, feed, litter condition, and 
unanticipated house conditions/events.  Findings were documented on log sheets. 
Mortality was monitored in each pen daily. 
The statistical analysis was completed with the SAS (SAS Institute, Cary, NC) 
statistical software package. All data were analyzed via one-way ANOVA using the 
GLM procedure. Differences were deemed significant at P<0.05 and means were 
separated by the PDIFF procedure. All animal handling and care practices were in 
accordance with an approved animal use protocol, IACUC 2017-0003. 
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Table 6 Experiment 2 - Diets and nutrient composition 
 Starter 
0-14 d 
Grower 
15-28 d 
Finisher 
29-42 d 
Ingredients, %    
       Corn, yellow grain 58.46 64.73 68.53 
Soybean meal, dehulled 
solvent 
34.48 29.33 26.64 
Bio/Phos 16/21 P 1.56 1.59 1.29 
Limestone 1.49 1.46 1.60 
Salt, plain 0.51 0.49 0.46 
Mineral mix
1
 0.05 0.05 0.05 
DL Methionine 0.28 0.08 0.16 
Lysine 0.17 0.02 0.12 
Vitamin Premix
2
 0.25 0.25 0.25 
Fat A/V blend 2.75 2.00 2.90 
Original XPC
3
 0.125 0.125 0.125 
.12 
    Calculated Nutrient Composition   
CP, % 22.02 19.80 17.99 
ME, kcal/lb 3048 3055 3151 
Crude Fat, % 5.30 4.74 5.73 
Lysine, % 1.30 1.05 1.00 
Methionine (M), % 0.61 0.39 0.44 
M+Cysteine, % 0.97 0.72 0.75 
Tryptophan 0.26 0.23 0.20 
Threonine  0.82 0.74 0.67 
Arginine 1.45 0.74 1.14 
Valine, % 1.00 0.91 0.82 
Calcium, % 0.92 0.90 0.89 
Available Phosphorous, 
% 
0.45 0.45 0.38 
Sodium 0.22 0.21 0.20 
Chloride, % 0.39 0.34 0.35 
 
1
Vitamin premix added at this rate yields 11,023 IU vitamin A, 3,858 IU vitamin D3, 46 
IU vitamin E, 0.0165 mg B12, 5.845 mg riboflavin, 45.93 mg niacin, 20.21 mg d-
pantothenic acid, 477.67 mg choline, 1.47 mg menadione, 1.75 mg folic acid, 7.17 mg 
pyroxidine, 2.94 mg thiamine, 0.55 mg biotin per kg diet.  The carrier is ground rice 
hulls. 
2
Trace mineral premix added at this rate yields 149.6 mg manganese, 55.0 mg 
zinc, 26.4 mg iron, 4.4 mg copper, 1.05 mg iodine, 0.25 mg selenium, a minimum of 
6.27 mg calcium, and a maximum of 8.69 mg calcium per kg of diet. The carrier is 
calcium carbonate and the premix contains less than 1% mineral oil. 
3
XPC is Diamond V Original XPC (Cedar Rapids, Iowa); corn will replace XPC in 
control diet. 
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4.3 Results 
  Results of mean body weights are summarized in Table 7. There were no 
significant differences (P>0.05) among the dietary treatments during the experimental 
period (1 to 42 d) but feed conversion ratio was numerically better at day 42 in 
vaccinated birds from the control diet when compared to XPC supplemented birds. 
Results of feed consumption and feed conversion ratio at day 42 are summarized on 
table 8. 
 
Table 7 Experiment 2 - Effects of diet containing XPC on body weight (BW) 
 Treatments
1 
 
 Vaccinated Not vaccinated  
  Diets
2
  Diets
2
  
Day of age  Control *  
BW (g) 
XPC * 
BW (g)  
Control * 
BW (g)  
XPC * 
BW (g) 
SEM 
1 48.06 47.50 46.13 47.75 0.44 
7 143.12 151.44 119.92 126.09 7.78 
14 331.01 368.23 327.61 313.63 11.66 
21 636.68 749.03 690.13 641.11 25.87 
28 1124.51 1269.68 1169.39 1130.72 50.34 
35 1742.91 1892.19 1777.90 1699.47 82.80 
42 2437.73 2600.13 2403.86 2332.70 110.13 
No significant differences were observed (P>0.05)  
* n= 15 birds per day, Ross 308. 
1
Vaccinated birds received live NDV LaSota strain vaccine at day 1 and 21; the not 
vaccinated birds receive no vaccination during the entire experimental period (1 to 42d)  
2
Diets with no XPC served as Control and XPC diets had inclusion of 1.25 kg of 
Original XPC /metric ton  
 
 
 
   41 
 
Table 8 Experiment 2 - Effects of a diet containing XPC on cumulative feed 
consumption and feed conversion ratio (FC) at day 42 
 Treatments
1 
 
 Vaccinated Not vaccinated  
  Diets
2
  Diets
2
  
Day of age  Control* 
Feed 
consumption 
(g) 
XPC* 
Feed 
consumption 
(g) 
Control* 
Feed 
consumption 
(g) 
XPC* 
Feed 
consumption 
(g) 
SEM 
14
3
 428.29 456.58 
 
423.97 435.97 
 
0.16 
28
4
 1690.93
c
 1863.60
a
 1749.96
bc
 1730.28
ab
 
 
0.02 
42
5
 4115.60
b
 4299.2
a
 
 
3983.34
b
 4059.3
ab
 
 
0.03 
FC at d42 1.72 1.70 1.75 1.73 0.02 
ab 
Means within a row lacking a common superscript differ significantly (P<0.05). 
* n= 15 birds per day, Ross 308. 
1
Vaccinated birds received live NDV LaSota strain vaccine at day 1 and 21; the not 
vaccinated birds receive no vaccination during the entire experimental period (1 to 42d)  
2
Diets with no XPC served as Control and XPC diets had inclusion of 1.25 kg of 
Original XPC /metric ton.  
3
End of starter diet; 
4
End of grower diet; 
5
End of finisher diet. 
 
 
Vaccinated XPC supplemented birds had a significantly (P<0.05) higher 
cumulative feed consumption compared to the vaccinated control birds at days 28 and 
42. There were no significant differences (P>0.05) between vaccinated birds and 
unvaccinated birds of the same dietary treatment at days 14, 28, and 42.  
The results of NDV-specific IgY levels are summarized in table 9. There was no 
evidence of a robust NDV-specific humoral immune response in either control or XPC 
supplemented birds. The highest NDV titer level observed during the experimental 
period was reached by birds in the control dietary treatment from the vaccinated group at 
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day 28, 7 days following secondary immunization, and it was significantly (P<0.05) 
higher than XPC supplemented birds. 
 
Table 9 Experiment 2 – Effect of XPC on mean anti-NDV Titers (IgY) 
 Treatments
1
  
 Vaccinated Not vaccinated  
 Diets
2
 Diets
2
  
Day of age  Control * 
(g)  
XPC *  
(g) 
Control *  
(g) 
XPC * 
(g) 
SEM 
4 8267.94 9140.09 10451.64 10175.64 814.67 
7 6524.16 5697.84 6948.80 6210.25 665.61 
14 2480.81 2077.51 2136.25 1971.13 363.72 
21 434.20 442.73 311.11 313.87 122.82 
24 625.12 364.90 262.40 57.43 190.18 
28 1048.25
a
 543.94
b
 2.04
c
 0
c
 150.57 
35 663.90
a
 454.78
a
 0
b
 0
b
 198.68 
42 439.60
a
 691.10
a
 0
b
 0
b
 108.64 
Calculated antibody titers (IgY) from the optical density measured by ELISA reader for 
the samples that were run through ELISA test specific for anti-Newcastle disease (ND) 
virus IgY production. 
On day of hatch the level of NDV-specific maternal antibodies was calculated and 
determined to be 11744.02 
 abc
 Means within a row lacking a common superscript differ significantly (P<0.05). 
Each value represents the mean value for each group.  
* n= 15 birds per day, Ross 308.  
1
Vaccinated birds received live NDV LaSota strain vaccine at day 1 and 21; the not 
vaccinated birds receive no vaccination during the entire experimental period (1 to 42d)  
2
Diets with no XPC served as Control and XPC diets had inclusion of 1.25 kg of 
Original XPC /metric ton  
 
Cell-mediated immunity was also measured during this trial. Results of peripheral 
lymphocyte and splenic lymphocyte subset analysis are summarized on table 10. On 
days, 7 and 24 cell-mediated immunity was measured via flow cytometry.  There were 
   43 
 
no significant differences (P>0.05) observed between the dietary treatments on the same 
sampling day however, CD3+, CD4+ and B-cell populations on the spleen were 
significantly (P<0.05) higher in both treatments on day 7 compared to day 24. 
Flow cytometry conducted on peripheral blood leukocytes showed no significant 
(P>0.05) differences between the dietary treatments on the same sampling day. The 
number of CD3+ cells was significantly higher on both treatments at day 7 compared to 
day 24. B-cell population in circulation at day 24 was significantly (P<0.05) higher in 
the control group compared to day 7. 
 
Table 10 Experiment 2 – Flow cytometry: Peripheral lymphocyte and splenic 
lymphocyte subset frequencies of vaccinated birds 
  Day of age *  
 7 24  
 Diets
1
  
 Control  XPC Control
 
 XPC SEM 
Spleen      
(%) CD3+ 5.99
a
 4.17
a
 43.76
b
 39.64
b
 3.89 
(%) CD4+ 1.65
a
 0.82
a
 5.55
b
 5.63
b
 0.58 
(%) CD8+ 2.90
a
 2.38
a
 23.73
b
 18.38
b
 2.15 
(%) Bu-1+ 46.44
a
 43.36
a
 15.42
b
 14.88
b
 2.08 
Circulation      
(%) CD3+ 3.24
a
 3.35
a
 9.97
b
 6.20
ab
 1.63 
(%) CD4+ 2.53
a
 1.37
a
 5.48
b
 2.50
a
 0.98 
(%) CD8+ 1.51 0.81 2.41 1.41 0.49 
(%) Bu-1+ 4.65 6.43 1.67 3.56 1.69 
* n= 5 birds per day/treatment, Ross 308. Vaccinated birds only. 
 
ab 
Means within a row lacking a common superscript differ significantly (P<0.05). 
Each value represents the mean value for each group.  
Vaccinated birds received live NDV LaSota strain vaccine at day 1 and 21  
1
Diets with no XPC served as Control and XPC diets had inclusion of 1.25 kg of 
Original XPC /metric ton  
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 Interferon-gamma release by T-cells after in vitro stimulation has been shown to 
be a good index of cell-mediated immunity in the chicken after vaccination. In this 
experiment, splenocytes and peripheral blood leukocytes harvested at 7 and 24 days of 
age were used to conduct this assay using sandwich ELISA and the mitogen 
concanavalin A. The optical densities obtained following the completion of this assay 
are summarized on table 11.  
 Optical densities of interferon gamma in circulation both in XPC supplemented 
birds and control birds were considerably low at 7 and 24 days of age. On day 24, the 
level of interferon gamma of control birds was significantly (P>0.05) higher than both 
dietary treatments at day 7. Interferon gamma in the spleen of birds from the control 
dietary treatment was significantly (P<0.05) higher at day 7 compared to both dietary 
treatments at day 24 and XPC supplemented birds at day 7. A higher level of interferon 
gamma in the spleen was detected at day 7 and 24 of the experimental period in both 
dietary treatments compared to the levels of this cytokine detected in circulation. 
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Table 11 Experiment 2 –Interferon Gamma levels of vaccinated birds –  
ELISA optical densities 
Day of age * 
    7 24 
Diets
1
Control XPC Control XPC SEM 
Circulation 0.10
a
0.099
a
0.138
b
0.109
ab
0.01 
Spleen 0.876
b
0.44
a
0.179
a
0.640
ab
0.22 
ab
 Means within a row lacking a common superscript differ significantly (P<0.05). 
Each value represents the mean value for each group.  
Interferon gamma secretion was measured using sandwich ELISA and concanavalin A 
as a mitogen. * n= 5 birds per day/treatment, Ross 308. Vaccinated birds only. 
Vaccinated birds received live NDV LaSota strain vaccine at day 1 and 21  
1
Diets with no XPC served as Control and XPC diets had inclusion of 1.25 kg of 
Original XPC /metric ton  
Our lab has observed in a previous experiment, Park et al., (2014), that central 
and peripheral immune organs produce different relative growth curves in XPC groups 
compared to a control dietary treatment. In this project, immune organ indexes defined 
as organ weight/body weight ratio were measured at 4, 7, 14, 21, 24, 28 and 35 days of 
age. In table 12, the effect of XPC on spleen index is summarized. On days 28 and 35 of 
the experimental period, unvaccinated birds had significantly (P<0.05) higher spleen 
index than vaccinated birds. 
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Table 12 Experiment 2 – Effect of XPC on spleen index 
 
 Treatments
1
  
 Vaccinated Not vaccinated  
 Diets
2
 Diets
2
  
Day *  Control
2
  XPC
2
  Control
2
  XPC
2
  SEM 
4 0.09 0.09 0.09 0.09 0.006 
7 0.11 0.11 0.12 0.12 0.007 
14 0.12 0.11 0.14 0.12 0.013 
21 0.15 0.16 0.16 0.14 0.01 
24 0.16 0.13 0.14 0.16 0.009 
28 0.14
a
 0.13
a
 0.18
b
 0.18
b
 0.014 
35 0.15
a
 0.13
a
 0.18
b
 0.19
b
 0.011 
Spleen index (defined as organ weight/body weight ratio) was determined. 
a, b 
Means within a row lacking a common superscript differ significantly (P<0.05). 
Each value represents the mean value for each group.  
* n= 15 birds per day, Ross 308. 
1
Vaccinated birds received live NDV LaSota strain vaccine at day 1 and 21; not 
vaccinated birds receive no vaccination during the entire experimental period (1 to 42d)  
2
Diets with no XPC served as Control and XPC diets had inclusion of 1.25 kg of 
Original XPC /metric ton  
 
In table 13, the effect of XPC on the bursa of Fabricius index is summarized. Significant 
differences (P<0.05) were observed on days 4 and 21. XPC supplemented birds had a 
significantly higher bursa of Fabricius index on day 4 compared to the control dietary 
treatment of the vaccinated group. On day 21, XPC supplemented birds of the 
unvaccinated treatment were significantly lower compared to both treatments of the 
vaccinated group. 
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Table 13 Experiment 2 – Effect of XPC on bursa of Fabricius index 
 Treatments
1
  
 Vaccinated Not vaccinated  
 Diets
2
 Diets
2
  
Day *  Control  XPC  Control  XPC SEM 
4  0.14
b
  0.19
a
   0.16
ab
   0.18
ab
 0.009 
7 0.18 0.17 0.19 0.17 0.009 
14 0.20 0.18 0.19 0.17 0.013 
21  0.23
a
  0.21
a
    0.20
 ab
  0.16
b
 0.018 
24 0.21 0.19 0.20 0.20 0.021 
28 0.20 0.17 0.19 0.17 0.011 
35 0.18 0.16 0.18 0.17 0.015 
Bursa of Fabricius index (defined as organ weight/body weight ratio) was determined. 
a, b,
 Means within a row lacking a common superscript differ significantly (P<0.05). 
Each value represents the mean value for each group.  
* n= 15 birds per day, Ross 308.  
1
Vaccinated birds received live NDV LaSota strain vaccine at day 1 and 21; not 
vaccinated birds receive no vaccination during the entire experimental period (1 to 42d)  
2
Diets with no XPC served as Control and XPC diets had inclusion of 1.25 kg of 
Original XPC /metric ton  
 
 
 
4.4 Discussion 
In order to expand the evaluation and further understanding of the 
immunomodulatory capacity of XPC on the adaptive immune system of broilers, a 
different NDV primary immunization schedule was utilized in this trial. Thus, the main 
objective of this trail was to evaluate the impact of a 1x dose of live LaSota strain NDV 
vaccine administered oculo-nasally on days 0 and 21 on early development of humoral 
and cell-mediated immune response in broilers and analyze the impact of this 
immunization schedule on the immunomodulatory capacity of
 
XPC.  
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The results obtained in a previous experiment conducted by our lab, Park et al., 
(2014), allowed us to observe differences in activation of cell-mediated immune 
response between the period following primary immunization and secondary 
immunization. In this experiment, an incomplete activation of cell-mediated immune 
response in birds from both dietary treatments was observed. There are no reports in the 
literature describing a similar development of CD4+ and CD8+ cells like the one 
observed in the current experiment.  
In the literature, there are reports of the influence of the virulence of a vaccine on 
the establishment and development of cell-mediated immunity. Rauw et al., 2009 
reported that an earlier and shorter cell-mediated immunity was generated from an NDV 
vaccine containing a less virulent strain, in comparison to vaccines containing more 
virulent strains, which resulted in a stronger and longer cell-mediated immunity. 
However, the results obtained in this experiment which used live LaSota strain NDV 
vaccine, a more virulent lentogenic strain compared to B1 strain, as a primary 
immunization indicate that a negative effect on the development of the adaptive immune 
system of broilers is generated. 
 In the poultry industry, live vaccines used in the field are designed to induce a 
strong humoral immune response in order to adequately establish adaptive immunity and 
establish immunological memory in the flock. A significantly different immunological 
response can be observed depending on the type of vaccine used, live or inactivated 
NDV vaccines.  
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In this experiment, cell-mediated immune responses were measured on days 7 
and 24. Recent studies have established that it is possible to detect cell-mediated 
immune responses to NDV soon after vaccination when a live NDV vaccine is used 
(Reynolds and Maraqa, 2000). The results obtained in this experiment show an absence 
of a strong development of cell-mediated immunity in both dietary treatments. Overall, a 
significantly (P<0.05) higher percent of lymphocytes in both the spleen and in 
circulation was seen at day 24 compared to day 7; CD3+ was significantly (P<0.05) 
higher at day 24 in both dietary treatments compared to day 7. However, B cells present 
in the spleen were significantly (P<0.05) higher in both treatments at day 7 compared to 
day 24.  
These results may indicate that live LaSota strain NDV vaccine may be causing 
an ineffective and incomplete activation of cell-mediated immune responses when used 
as primary immunization on the first day of age of a broiler as it was observed in the 
current experiment. Another potential explanation for the incomplete activation observed 
in the flow cytometry assay could be that the migration of T-cells and B cells occurs 
faster than we hypothesize and the cells might be undergoing proliferation somewhere in 
in the organism’s lymphoid aggregate by the time the assay is conducted.  
It is important to notice that within the complexity of the adaptive immune 
system it is often times difficult to draw clear direct cause and effect conclusions 
because many factors are involved in the immune response. The vaccine used in this 
experiment, live NDV LaSota strain, is more virulent compared to the B1 strain but still 
lentogenic and is widely used in the poultry industry typically only as a secondary 
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immunization. In the immune system, many different types of cytokines constitute the 
major instrument for immune cell communication and they act as immune modulating 
agents regulating both innate and adaptive immunity response to antigens and infectious 
agents (Stenger and Rollinghoff, 2001).  
More research is needed to better understand the specific cell-mediated immunity 
mechanisms that aid in the immunological response against NDV. In prior studies, birds 
that were determined to have cell-mediated immunity specific for NDV via blastogenesis 
microassay with inactivated NDV, were not protected from lethal challenge in the 
absence of HI antibodies but birds with NDV-specific antibodies were shown to be 
protected (Alizadeh, 2012).  Russell et al., (1997) indicated that antibodies are the key 
modulators of protection, but that cell-mediated immunity likely contributes to decrease 
viral shedding through target killing of NDV infected cells.  
A good measurement of activation of cell-mediated immunity includes analyzing 
the expression of interferon gamma. Interferon gamma plays an important role in the 
activation of macrophages and has effector functions in the entire immune system. In 
this experiment, interferon gamma secreted by splenocytes and interferon gamma 
expression detected in circulation were calculated by using a common mitogen, 
concanavalin A, a classical T-cell mitogen (Ginsburg et al., 1971). The results are 
summarized in table 11. A higher level of interferon gamma in the spleen was detected 
at day 7 and 24 of the experimental period on both dietary treatments compared to the 
levels of this cytokine detected in circulation. 
   51 
 
 Overall, the expression of interferon gamma was low in both dietary treatments. 
These results further strengthen the observations made in this experiment and the 
hypothesis that the use of live LaSota strain NDV vaccine resulted in an incomplete 
activation and development of a successful humoral and cell mediated immune response. 
However, there is a possible explanation for the low levels of interferon gamma and the 
incomplete activation of adaptive immunity, which caused an incomplete development 
of humoral and cell mediated immunity in all birds from both dietary treatments.  The 
primary vaccination could have triggered the activation of high levels of interlueukin-10, 
which has been described by Zhiguang et al., (2016) as being immunosuppressive in 
chickens as it is in mammals.  
Interleukin-10, a multifunctional cytokine, is able to inhibit activation and 
effector function of T cells, monocytes, and macrophages. The principal routine function 
of IL-10 appears to be to limit and ultimately terminate inflammatory responses as well 
as to regulate B cells and helper T cells, which makes it play a key role in differentiation 
and function of T regulatory cells (Moore et al., 2001). Further study of the specific 
mechanisms that will trigger the inhibition seen in this trail is needed; this will also aid 
in the understanding of interleukin-10 role in broilers and the potential to use this 
understanding to enhance the immunological benefit of vaccines. 
Protection by NDV-specific antibodies has been reported to be fundamental 
against a live NDV challenge. The results of NDV-specific humoral immune response 
observed in this trial are summarized in table 7. An absence of a robust humoral immune 
response was observed in vaccinated birds from both dietary treatments. At day 28, 7 
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days post-secondary immunization, only the control birds generated a clear NDV-
specific humoral immune response. This weak antigen-specific humoral immune 
response was significantly (P<0.05) higher than the one observed on XPC supplemented 
birds. Unvaccinated birds did not show any NDV-specific humoral immune response, as 
expected, and its maternal antibodies followed a natural decline. This group showed an 
absence of a humoral response to any potential natural immunological challenge present 
at the farm that could have interfered with the establishment of adaptive immunity in the 
vaccinated birds. There are no literature reports under a similar experimental design 
showing comparable results of the antigen-specific humoral immune response observed 
in this trial.  
The results of XPC supplementation in the diet of Ross 308 broilers on body 
weight and feed conversion ratio at day 42 are summarized in table 6. No significant 
differences (P>0.05) in body weights were observed throughout the experimental period 
(1-42d) between the dietary treatments. There were no significant differences (P>0.05) 
between vaccinated birds and unvaccinated birds of the same dietary treatment at days 
14, 28, and 42 which indicates that the vaccine did not have an effect on cumulative feed 
consumption. Feed conversion ratio at day 42 was numerically improved in XPC 
supplemented birds but no significant differences (P>0.05) were observed.  
Baurhoo et al., (2009) reported that inclusion of yeast-derived carbohydrates in 
broiler diets did not result in a significant difference on growth performance in a non-
infectious setting. Our lab has consistently found no significant differences (P>0.05) in 
body weights of Ross 308 birds from XPC-containing diet compared to birds 
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supplemented a control diet but feed conversion ratio has tended to improve by day 42 in 
XPC supplemented birds. 
4.5 Conclusion 
In a previous experiment by this lab, Park et al., (2014), the immunomodulatory 
capacity of XPC was measured by immunizing birds on day 1 using live B1 strain NDV 
vaccine followed by a secondary immunization at day 21 with live LaSota strain NDV 
vaccine. The purpose of vaccination is not only to generate humoral immune response 
against a specific pathogen but also to establish cell-mediated immunity. 
 The main objective of this study was to evaluate the impact of a 1x dose of live 
LaSota strain NDV vaccine administered oculo-nasally on days 0 and 21 on early 
development of humoral and cell-mediated immune response in broilers and analyze the 
impact of this immunization schedule on the immunomodulatory capacity of XPC. 
The results indicate that there was a detrimental effect on the development of the 
adaptive immune system of broilers vaccinated with live LaSota strain NDV vaccine. No 
robust NDV-specific humoral immune response was observed in birds from any of the 
dietary treatments. Control vaccinated birds reached a non-robust but significantly 
(P<0.05) higher antigen-specific humoral immune response compared to XPC 
supplemented birds on day 28, 7 days after secondary immunization.  
Cell mediated immunity was also measured and the results indicated that there 
was an incomplete activation of T-cell lymphocytes on both the spleen and in 
circulation. B-cell population in the spleen and in circulation had a similar trend. 
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Overall, a higher percent of T-cell subpopulations in the spleen and in circulation were 
observed on day 7 compared to day 24. 
The results of the organ index analysis showed an overall higher organ 
development in the unvaccinated birds compared to the vaccinated treatment except on 
day 21 where bursa of Fabricius was significantly (P<0.05) higher in the vaccinated 
birds compared to the unvaccinated treatment. The level of interferon gamma detected in 
circulation and in spleen was low and consistent with ELISA and flow cytometry data.  
The results of this experiment strongly suggest that the use of live LaSota strain 
NDV vaccine at day 1 of age in broilers results in a severe detrimental effect on the 
development and establishment of adaptive immunity. The effects of the immunization 
schedule used in this experiment resulted in an absence of a robust NDV-specific 
humoral immune response in vaccinated birds; XPC supplemented birds suffered a more 
severe effect on the development of their adaptive immunity.  
The unvaccinated birds showed a normal decaying of maternal antibodies. No 
significant differences were observed in live production parameters between the dietary 
treatments. The absence of an antigen-specific humoral immune response in 
unvaccinated birds shows the absence of a natural immunological challenge in the farm 
during the experimental period and allows for the further reliability of the results 
observed in vaccinated birds.  
The results of this experiment indicate that the use of a more virulent strain of 
NDV vaccine compared to B1 strain can have a severe impact on the establishment of a 
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broiler’s adaptive immunity. This is practical information for the poultry industry as it 
relates to immunization schedules.  
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5. EVALUATING THE INFLUENCE OF MATERNAL ANTIBODIES ON THE 
EFFICACY OF LIVE NEWCASTLE DISEASE VIRUS VACCINE ON XPC
TM 
SUPPLEMENTED BROILERS 
  
 
5.1 Introduction 
The poultry industry needs new strategies to maintain production levels while 
eliminating the use of antibiotics and maintaining bird health. Our lab as a potential 
strategy to combat the problems faced in antibiotic free production has identified the 
functional metabolites of Diamond V Original XPC
TM
 (XPC). This potential strategy can 
result in enhanced immune function and poultry health. 
This study’s objective was to evaluate the role of maternal antibodies on XPC 
modulation of antigen-specific humoral immune response in broilers. One-day old Ross 
308 broilers (180) were randomly assigned to a factorial arrangement of three 
vaccination protocols and two diets (XPC or control (CON)). In the first protocol broiler 
chicks were immunized with live Newcastle Disease Virus (NDV) B1 strain vaccine at 
day 1. In the second protocol broiler chicks were vaccinated with live LaSota strain 
NDV vaccine at day 1.  
Both protocols received a secondary immunization with live LaSota strain NDV 
vaccine at day 21. Protocol three consisted of delaying immunizing the chicks until the 
level of maternal antibodies decayed below 2000 NDV titer level. Once the level of 
maternal antibodies was verified, broilers were immunized with live LaSota strain NDV 
vaccine. NDV-specific IgY was measured using ELISA on days 1, 7, 14, 21, 28, and 35. 
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 Feed consumption, cumulative feed conversion ratio and body weights were also 
measured. XPC birds reached a higher and faster titer level one-week following 
secondary immunization in protocol 1. Protocol 3 resulted in birds reaching the highest 
NDV-titer level during the trial with XPC birds reaching the highest NDV-titer level. 
Protocol 2 had the lowest NDV-titer level observed in the trial. Feed conversion was 
higher in both dietary treatments for protocol 3 compared to protocols 1 and 2.  
The results indicate that XPC favorably modulated the broiler immune system 
against NDV specific adaptive immunity. The level of maternal antibodies appears to 
have a role on the impact of XPC on the adaptive immune system which is consistent 
with previous data from our lab.  
5.2 Materials and Methods  
In order to evaluate the influence of maternal derived antibodies on the efficacy 
of live NDV vaccine on XPC supplemented birds a 35-day trial was conducted. The 
main objective of this study was to evaluate the role of maternal antibodies on the 
immunomodulatory capacity of XPC on antigen-specific humoral immune response in 
broilers.  
A total of 180-one-day old Ross 308 broilers were randomly assigned to a 
factorial arrangement of three vaccination protocols and two diets (XPC or control). 
XPC was included into treatment diet at 1.25 kg/metric ton for starter, and grower diets. 
Feed was stored in plastic lined 30 gallon barrels labeled with date, diet, treatment code 
and experiment identification number. A 2x batch of the control diet was mixed and split 
into two equal parts prior to pelleting. The control feed was pelleted and placed in 
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barrels. The treated feed was returned to the mixer and an appropriate amount of XPC 
was added and allowed to mix for 10 minutes prior to pelleting and storage in barrels. 
Composite feed samples from each feed mixing were collected and stored at -20
o
C until 
submitted for proximate analysis.  
In the first protocol, broiler chicks were immunized with live NDV B1 strain 
vaccine on day 1 (USDA Product code: 1711.10; Merial Select Laboratories, 
Gainesville, Georgia). In the second protocol broiler chicks were vaccinated with live 
LaSota strain NDV vaccine on day 1 (USDA Product code: 1721.11); Merial Select 
Laboratories, Gainesville, Georgia). In both protocols, chicks received a secondary 
immunization with live LaSota strain NDV vaccine at day 21. Protocol three consisted 
of delaying immunization of the chicks until the level of maternal antibodies decayed 
below 2000 NDV titer level. Once the level of maternal antibodies was verified, broilers 
were immunized with live LaSota strain NDV vaccine. Each treatment group of 15 birds 
had a replicate pen for a total of 12 pens.   
Antigen-specific humoral immune response was assessed by NDV-specific IgY 
using ELISA on days 1, 7, 14, 21, 28, and 35. Blood samples were obtained by 
venipuncture; 0.5ml blood samples were collected. A Newcastle Disease Antibody Test 
Kit (Synbiotics Corp., San Diego, CA) was used to assess the establishment of humoral 
immune response. The average of positive and normal control serum absorbance (Optical 
Density as O.D.) was calculated. Each sample was analyzed, and antibody titers were 
calculated using the formula: S/P (Sample to positive ratio) = (Absorbance of sample – 
Average of N control absorbance)/ (Average of positive control absorbance – Average of N 
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control absorbance). The final titer was calculated based on the following formula provided 
in manufacturer’s instructions: Final Titer = ANTILOG (1.464 x (Log10S/P) + 3.740). 
 Cumulative feed conversion ratio, feed consumption, and body weights were 
obtained. All birds were housed at TAMUPRC. Birds were fed a corn/soybean meal base 
diet (table 14). Starter (0-21d), grower (22-35d) diets were manufactured at TAMUPRC 
feed mill. Feed and water was provided ad libitum during the entire trial.   
No drug therapy was used during the study. When any study personnel entered a 
pen (i.e., to collect birds for study procedures), plastic boots and gloves were utilized. 
The person who was inside the pen as it stepped out to avoid carrying any fecal material 
throughout the facility removed the plastic boots and gloves. Plastic boots and plastic 
gloves were discarded in an appropriate container after use. 
All pens were monitored three times daily for general flock condition, 
temperature (recorded on log sheets), lighting, water, feed, litter condition, and 
unanticipated house conditions/events.  Findings were documented on log sheets. 
Mortality was monitored in each pen daily. 
All data were analyzed with the SAS (SAS Institute, Cary, NC) statistical 
software package and analyzed via one-way ANOVA using the GLM procedure. 
Differences were deemed significant at P<0.05 and means were separated by the PDIFF 
procedure. All animal handling and care practices were accordance with an approved 
animal use protocol, IACUC 2016-0103 reference number 047515. 
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Table 14 Experiment 3 – Experimental diets and nutrient composition 
 Starter 
0-21 d 
Grower 
22-35 d 
Ingredients, %   
       Corn, yellow grain 58.46 64.73 
Soybean meal, dehulled solvent 34.48 29.33 
Bio/Phos 16/21 P 1.56 1.59 
Limestone 1.49 1.46 
Salt, plain 0.51 0.49 
Mineral mix
1
 0.05 0.05 
DL Methionine 0.28 0.08 
Lysine 0.17 0.02 
Vitamin Premix
2
 0.25 0.25 
Fat A/V blend 2.75 2.00 
Original XPC
3
 0.125 0.125 
   Calculated Nutrient Composition  
CP, % 22.02 19.80 
ME, kcal/lb. 3048 3055 
Crude Fat, % 5.30 4.74 
Lysine, % 1.30 1.05 
Methionine (M), % 0.61 0.39 
M+Cysteine, % 0.97 0.72 
Tryptophan 0.26 0.23 
Threonine  0.82 0.74 
Arginine 1.45 0.74 
Valine, % 1.00 0.91 
Calcium, % 0.92 0.90 
Available Phosphorous, % 0.45 0.45 
Sodium 0.22 0.21 
Chloride, % 0.39 0.34 
1
Vitamin premix added at this rate yields 11,023 IU vitamin A, 3,858 IU vitamin D3, 46 
IU vitamin E, 0.0165 mg B12, 5.845 mg riboflavin, 45.93 mg niacin, 20.21 mg d-
pantothenic acid, 477.67 mg choline, 1.47 mg menadione, 1.75 mg folic acid, 7.17 mg 
pyroxidine, 2.94 mg thiamine, 0.55 mg biotin per kg diet.  The carrier is ground rice 
hulls. 
2
Trace mineral premix added at this rate yields 149.6 mg manganese, 55.0 mg 
zinc, 26.4 mg iron, 4.4 mg copper, 1.05 mg iodine, 0.25 mg selenium, a minimum of 
6.27 mg calcium, and a maximum of 8.69 mg calcium per kg of diet. The carrier is 
calcium carbonate and the premix contains less than 1% mineral oil. 
3
XPC is Diamond V Original XPC (Cedar Rapids, Iowa); corn will replace XPC in 
control diet. 
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5.3 Results 
 The results for serum levels of NDV-specific IgY are presented in table 15. 
There was a robust and faster establishment of NDV-specific humoral immune response 
of XPC supplemented birds in protocol 1 compared to control birds on day 28, (P<0.05). 
The lowest level of NDV titers were observed in protocol 2, LaSota strain as primary 
immunization. This protocol also resulted in an absence of a robust NDV-specific 
humoral immune response. The highest level of NDV titers was seen in birds from 
protocol 3; XPC supplemented birds reached a significantly (P<0.001) higher level of 
NDV titers at day 35 compared to control birds and were able to mount the highest NDV 
specific humoral immune response compared to all other treatments in the trial. 
The results obtained in this experiment concerning the effect of XPC on mean 
body weights are summarized in Table 16. There was a significant (P<0.05) difference 
observed in feed conversion ratio between dietary treatments of protocol 3 compared to 
1 and 2 on day 35. This however, was determined to be a vaccination protocol effect and 
not a dietary effect. Feed consumption and feed conversion ratio at day 35 are 
summarized in table 17.  
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Table 15 Experiment 3 – Effect of XPC on mean NDV Titers (IgY) 
Vaccination Protocols
1
 
 Protocol 1 Protocol 2 Protocol 3  
 Diets
2
 Diets
2
 Diets
2
  
Day 
*
 Control XPC Control XPC Control XPC SEM 
7 6991.03 7700.39 6856.71 8289.03 7297.21 7260.82 489.29 
14 1620.01 2174.68 1923.39 2255.66 1873.11 1996.01 287.95 
21 901.09 821.43 836.25 1106.71 557.12 451.93 145.51 
28 1041.34
bA
 1805.01
aA
 740.67
B
 966.51
B
 60.20
B
 250.21
B
 187.06 
35 1662.45
B
 1436.20
B
 1135.21
B
 785.11
B
 2020.76
Ab
 2829.34
aA
 439.83 
Calculated antibody titers (IgY from the optical density measured by ELISA reader for 
the samples that were run through ELISA test specific for anti-Newcastle disease (ND) 
virus IgY production.  
On day of hatch the level of NDV-specific maternal antibodies was calculated and 
determined to be 11363.83  
A, B
 Means within a row lacking a common superscript differ significantly (P<0.001).  
a, b Means within a row lacking a common superscript differ significantly (P<0.05). 
Each value represents the mean value for each group.  
* n= 15 birds per day, Ross 308 
1
Vaccination Protocol 1: B1 at day 1, LaSota at day 21; Protocol 2: LaSota at day 1 and 
day 21; Protocol 3: B1 at day 21, once the level of maternal antibodies decayed below 
2000 NDV titer. 
2
Diets with no XPC served as Control and XPC diets had inclusion of 1.25 kg of 
Original XPC /metric ton  
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Table 16 Experiment 3 - Effects of diet containing XPC on body weight (BW) 
Vaccination Protocols
1
 
 Protocol 1 Protocol 2 Protocol 3  
             Diets
2
 Diets
2
  Diets
2
  
Day * Control 
BW (g) 
XPC 
BW (g) 
Control 
BW (g) 
XPC 
BW (g) 
Control 
BW (g) 
XPC 
BW (g) 
SEM 
1 38.13 39 39.53 38.50 39.03 38.33 0.47 
35 2281.90 2140.63 2224.40 2206.88 2168.80 2175.01 127.69 
* n= 15 birds per day, Ross 308. 
a, b
 Means within a row lacking a common superscript differ significantly (P<0.05). 
1
Vaccination Protocol 1: B1 at day 1, LaSota at day 21; Protocol 2: LaSota at day 1 and 
day 21; Protocol 3: B1 at day 21, once the level of maternal antibodies decayed below 
2000 NDV titer. 
2
Diets with no XPC served as Control and XPC diets had inclusion of 1.25 kg of 
Original XPC /metric ton  
 
 
Table 17 Experiment 3 - Effects of diet containing XPC on cumulative                  
feed consumption (CFC) and feed conversion ratio (FC) at day 35 
Vaccination Protocols
1
 
 Protocol 1 Protocol 2 Protocol 3  
             Diets
2
 Diets
2
  Diets
2
  
Day * Control 
CFC (g) 
XPC 
CFC (g) 
Control 
CFC (g) 
XPC 
CFC (g) 
Control 
CFC (g) 
XPC 
CFC (g) 
SEM 
35
3
 3604.19 3437.92 3520.38 3599.13 4074.75 3818.63 100.80 
FC 1.61
B
 1.64
B
 1.61
B
 1.66
B
 1.82
A
 1.80
A
 0.07 
* n= 15 birds per day, Ross 308. 
A, B
 Means within a row lacking a common superscript differ significantly (P<0.001). 
1 
Vaccination Protocol 1: B1 at day 1, LaSota at day 21; Protocol 2: LaSota at day 1 and 
day 21; Protocol 3: B1 at day 21, once the level of maternal antibodies decayed below 
2000 NDV titer.
2 
Diets with no XPC served as Control and XPC diets had inclusion of 
1.25 kg of Original XPC /metric ton. 
3
End of grower diet. 
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5.4 Discussion 
The main objective of this experiment was to evaluate the role of maternal 
antibodies on XPC modulation of antigen-specific humoral immune response in broilers. 
The factorial arrangement of three vaccination protocols and two diets (XPC or control 
(CON)) described in detail in the materials and methods section allowed for the 
identification of a vaccination protocol that allows for a faster and robust establishment 
of NDV-specific humoral immune response in broilers.  
Feed conversion ratio was measured during the experimental period. A 
significantly (P<0.05) higher feed conversion ratio at day 35 for protocol 3 was observed 
compared to protocols 1 and 2. This was determined to be a vaccination protocol effect.  
There are no reports in the literature utilizing the same vaccination protocol used in this 
experiment that studied the effect on feed conversion ratio. We hypothesize that the 
differences in feed conversion at day 35 are the result of birds from vaccination protocol 
3 losing gain to feed consumption ratio as a result of the vaccination they received on 
day 21, which was the first time these birds encountered NDV in addition to having lost 
their protective level of maternal antibodies.  
Body weight results showed no significant differences (P>0.05) during the 
experimental period (1 to 35d) as a result of a dietary treatment effect or vaccination 
protocol effect. Morales-Lopes and Brufau, (2013) showed that supplementation of 
Saccharomyces cerevisiae cell walls did not result in any significant differences in feed 
intake and body weight gain, but feed conversion ratio on days 21 and 28 was better 
compared to the control group.  
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The experimental design allowed for the study of the effect of maternal 
antibodies on XPC and control birds as well as the interaction between vaccination 
protocols and maternal antibodies on NDV-specific humoral immune response. On day 
28 a significantly (P<0.001) higher anti-NDV titer level between XPC birds from 
protocol 1 and the birds from both dietary treatments from protocols 2 and 3 was 
observed. On day 28 for protocol 1 a significantly (P<0.05) higher titer was observed for 
XPC supplemented birds compared to controls. 
There are reports in the literature (Haghighi et al., 2005; Ghosh et al., 2012) that 
have shown that supplementation of diet with yeast-derived carbohydrates can enhance 
humoral immune responses by increasing the antibody production. The ELISA results in 
this experiment indicate that the level of maternal antibodies and vaccination schedule 
do have an effect on the development of antigen-specific humoral immune response in 
broilers fed a control diet.  
Additionally, they suggest that the level of maternal antibodies on day 1 appears 
to modulate the effect of XPC on the adaptive immune system of broilers. The results of 
this experiment also strongly indicate that vaccination schedule also has a significant 
impact on the ability of XPC to modulate the adaptive immune system of broilers. 
A more robust NDV-specific humoral immune response was observed on birds 
from vaccination protocol three. Protocol three consisted of delaying immunization of 
the chicks until the level of maternal antibodies decayed below 2000 NDV titer level. 
Once the level of maternal antibodies was verified, broilers were immunized with live 
LaSota strain NDV vaccine, day 21. XPC supplemented birds from this group reached 
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the highest NDV titer level observed in the trial and their titer level was significantly 
(P<0.05) higher from control birds. This vaccination protocol only included one 
immunization, after the level of maternal antibodies had dropped to baseline levels. 
Maternal antibodies are antibodies that allow for the establishment of passive immunity 
in chicks that receive these antibodies from the hen through the egg yolk. The 
interference in vaccine-induced humoral immune response by maternal antibodies is 
well studied. It can result in a significant difference in the development of antigen-
specific humoral immune response in birds as was seen in this experiment.  
An immunosuppressive effect of maternal antibodies on humoral immune 
response following vaccination has been attributed to neutralization of vaccine virus by 
these antibodies (Siegrist et al., 1998). Naqi et al. (1983) showed that birds with high 
levels of IBDV maternal antibodies had no immune response activation to IBDV 
vaccines, whereas birds with low maternal antibodies showed delayed response to 
vaccines. It has been reported also that vaccination of birds against Infectious Bronchitis 
Virus in the presence of maternal antibodies at d1 of age quickens the clearance rate of 
maternal antibodies (Mondal and Naqi, 2001). 
5.5 Conclusion  
The results observed in this experiment concur with the results obtained in a 
previous experiment conducted in our lab by Park et al., (2014). In addition, they 
corroborate the hypothesis that the level of maternal antibodies influences the 
immunomodulatory effect of XPC on the adaptive immune system of broilers. On day 
28, a significantly (p>0.05) higher humoral response was observed in XPC birds in 
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comparison to the control group, in vaccination protocol 1. The results seen in 
vaccination protocol 2 are comparable to the ones obtained in experiment 2. The results 
restate the conclusion from experiment 2 about the negative impact that NDV live 
LaSota strain vaccine has on the development of adaptive immune response.  
Vaccination protocol 3 resulted in the highest level of NDV titers following 
immunization at day 21. Vaccination protocol 3 allowed for the measurement of the 
immunomodulatory effect of XPC to be seen without the interference by maternal 
antibodies. It is important to mention that maternal antibodies are pathogen specific and 
are able to act similarly to naturally induced antibodies. 
No significant differences (P>0.05) in body weights were observed but feed 
conversion ratio at day 35 was significantly (P<0.05) higher in birds from protocol 3 
compared to protocols 1 and 2. This was concluded to be a vaccination protocol effect 
and not a dietary effect.  
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6. SUMMARY 
 
The poultry industry has evolved to become an efficient, high yield, and 
economically lucrative industry through the development of better ventilation, housing, 
animal care, use of antibiotics and intense research. However, due to high levels of 
production and the use of antibiotics in combination with consumer demand, media 
pressure and growing concern over antibiotic-resistant bacteria, and the potential for 
their residual presence in poultry products; the poultry industry has been forced to seek 
and develop new strategies for pathogen control, animal health, and food safety without 
the use of antibiotics.  
The functional metabolites of a Saccharomyces cerevisiae fermentation product 
from Diamond V (Cedar Rapids, Iowa) Original XPC
TM
 (XPC) have been identified by 
our lab as a potential strategy for use in the poultry industry, particularly in antibiotic 
free production. The need to find effective, economically sound and practical strategies 
in order to maintain high levels of production in the poultry industry while continuing 
appropriate animal care has become a top priority in the industry around the world. 
Therefore, it is imperative to continue thorough research in that field.  
This study involving three different experiments had the objective to 1) evaluate 
the effect of dietary XPC supplementation on the early development of the adaptive 
immune response in broilers, 2) assess the impact of a 1x dose of live LaSota strain 
NDV vaccine administered oculo-nasally on days 0 and 21 on early development of 
humoral and cell-mediated immune response in broilers and analyze the impact of this 
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immunization schedule on the immunomodulatory capacity of XPC, 3) to evaluate the 
role of maternal antibodies on XPC modulation of antigen-specific humoral immune 
response in broilers. 
The most robust antigen specific humoral immune response observed at the 
completion of this series of three experiments was observed in XPC supplemented birds 
vaccinated only at day 21; once maternal antibodies had been cleared. The results also 
indicate that if the level of maternal antibodies is relatively high at day of vaccination 
XPC supplemented broilers can reach a faster and more robust NDV-specific humoral 
immune response when the primary immunization is live B1 NDV vaccine as opposed to 
LaSota. 
The results obtained from this series of three experiments that overall aimed to 
assess the impact of the immunomodulatory capacity of XPC on the adaptive immune 
system of broilers indicate that the functional metabolites of XPC have a positive effect 
on the establishment of antigen-specific humoral immune response in broilers. The 
results show a more robust response, and depending on the primary immunization and 
level of maternal antibodies, a faster establishment of antigen-specific humoral response 
by XPC supplemented birds.  
However, the results from the flow cytometry conducted to measure the 
development of cell-mediated immunity did not show any significant differences 
between the control and XPC supplemented diets nor clear trends amongst the dietary 
treatments. It is unclear what specific mechanisms or genes in the adaptive immune 
system are being modulated by XPC. Further research is needed in the area of gene 
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expression in order to identify the genes that are being upregulated and downregulated 
and are being responsible for the development of a more robust adaptive immune 
response. 
 Supplementation of XPC did not result in a significant improvement of growth 
performance. Throughout the literature there are inconsistent reports concerning the 
effects of yeast-derived products on broiler growth. One potential explanation for the 
difference in results could be associated with experimental and environmental 
conditions, as well as the type and concentrations of yeast products used in different 
studies and the genetic background of the birds utilized.  
It is clear that after the completion of this series of experiments, more research is 
needed to better understand the mechanisms in the establishment of adaptive immunity 
that XPC modulates in order to fully assess its potential value for the industry. 
One of the objectives of this study was to evaluate the role of maternal antibodies 
on XPC modulation of antigen-specific humoral immune response in broilers. It is clear 
that the efficacy of NDV vaccine can be enhanced if the level of maternal antibodies is 
low prior to the immunization day (day 21 of age in this study). One cost associated to 
this immunization schedule however, can be the dysregulation of feed consumption and 
as a result a negative effect in feed conversion ratio; this as a result of a natural reaction 
from the birds to the vaccine as they have never been exposed to the antigen previously. 
The inconsistent results regarding the effects of probiotics and prebiotics  on 
adaptive humoral immune response suggest that the immunomodulatory effects of these 
products cannot be generalized due to a number of factors such as genetic background of 
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the host, the type of the probiotic and prebiotic used, immunization regimen as well as 
experimental conditions. 
The results of this study allow for the identification of live LaSota strain NDV 
vaccine as potentially detrimental to the development of adaptive immunity in broilers 
when used at one-day of age.  
This study reinforces the widely accepted theory that maternal antibodies can 
interfere with vaccine efficacy and as a result fail to induce a full immunological benefit. 
In addition, this study provides practical information to the poultry industry regarding 
vaccination protocols and use of XPC in broilers, and it supplies valuable information 
about XPC that can result in a better understanding of its immunomodulatory capacity in 
broilers. It assess its potential value as a strategy to be used by the poultry industry to 
enhance immune function and poultry health.    
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APPENDIX 
 
XPC
TM
 by Diamond V  
Diamond V’s Original XPCTM is an all-natural fermentation product that contains 
bioactive components produced using proprietary anaerobic fermentation technology of 
Saccharomyces cerevisiae; it is composed of metabolites, beta-glucans, and mannans 
that promote animal health and performance (Diamond V Original XPC
TM
, n.d.).  
The metabolites in Original XPC
TM
 help to balance the gut microbiota in order to 
support optimum digestive health, and the antioxidant activity of XPC
TM
 ads immune 
function (Diamond V Original XPC
TM
, n.d.).  
Research has shown that XPC supports production performance for all poultry, 
specifying in egg production, quality and efficiency for layers. (Diamond V Original 
XPC
TM
, n.d.) It is used in all classes of livestock, poultry, equine and pet diets.  
 
 
